US Pat. No. 10,246,560

PLGA-MODIFIED POLYETHYLENIMINE SELF-ASSEMBLY NANOTECHNOLOGY FOR NUCLEIC ACID AND DRUG DELIVERY

Baylor College of Medicin...

1. A composition comprising a copolymer consisting of lactide-co-glycolide and PEI, wherein single lactide-co-glycolide units are each conjugated to primary amines of PEI through an amide linkage, wherein the w/w ratio of LGA to PEI is 0.5:1 to 5:1,wherein the composition further comprises at least one therapeutic and/or diagnostic agent and wherein the composition is in the form of a nanoparticle.
US Pat. No. 10,244,769

METHOD OF CUTTING A PORK LOIN AND A BONELESS PORK LOIN PRODUCT

Tyson Foods, Inc., Sprin...

1. A method of cutting a boneless elongated meat member, the elongated meat member being the loin of a hog carcass in substantially the shape of a cylinder, the elongated meat member having a first end, a second end, and a longitudinal axis between the first and second ends, the method comprising:separating the boneless elongated meat member into at least three elongated meat portions and each of the at least three elongated meat portions have a first end, a second end, and a longitudinal axis between the first and second ends, wherein two of the at least three elongated meat portions are exterior elongated meat portions and each exterior elongated meat portion is substantially in the shape of a half-cylinder, and at least one of the at least three elongated meat portions is an interior elongated meat portion positioned between the two exterior elongated meat portions and the interior elongated meat portion is substantially in the shape of a rectangular prism that includes a top surface, a bottom surface opposite the top surface, and four exterior side surfaces between the top and bottom surfaces, wherein two of the four exterior side surfaces are elongated side surfaces each running the length of the interior elongated meat portion and wherein each of the elongated side surfaces are opposite each other, and two of the four exterior side surfaces are short side surfaces positioned between the elongated side surfaces and wherein one short side surface is at the first end and the other is at the second end of the interior elongated meat portion, and wherein the short side surfaces substantially define a width of the interior elongated meat portion and wherein a thickness of the interior elongated meat portion is substantially defined between the top and bottom surfaces, wherein the separating step includes cutting the elongated meat member end to end in substantially the same direction of the longitudinal axis the length of the elongated meat member, wherein the at least three elongated meat portions are each about 0.0625 inches to about 4.0 inches thick; and
dividing the at least one interior elongated meat portion into a plurality of smaller meat pieces, wherein the dividing step includes cutting the at least one interior elongated meat portion substantially perpendicular with respect to the longitudinal axis of the interior elongated meat portion and between the top and bottom surfaces in the same direction as its thickness.
US Pat. No. 10,245,281

GLYCOSAMINOGLYCANS

Agency for Science, Techn...


following digestion with heparin lyases I, II and III and then subjecting the resulting disaccharide fragments to capillary electrophoresis analysis; and
HS7 is heparin-free and provides high activating affinity for VEGF.
US Pat. No. 10,246,817

TREATMENT OF A FABRIC ARTICLE

KONINKLIJKE PHILIPS N.V.,...

1. A method of treating a fabric article so that it is imparted with a characteristic smell normally associated with fabric articles that have been exposed to natural sunlight, the method comprising:positioning a fabric article to be treated in an enclosure,
irradiating, by one or more ultraviolet lamps under control of a controller, said fabric article positioned in said enclosure with ultraviolet light with a wavelength of between 280 nm and 320 nm for a first time period, and
irradiating, by said one or more ultraviolet lamps under control of said controller, said fabric article positioned in said enclosure with ultraviolet light with a wavelength of between 320 nm and 400 nm for a second time period,
distributing charged particles via an ion generator situated an exit region of the enclosure causing surrounding air passing out of the enclosure at said exit region to become charged,
switching off the ultraviolet light once a required radiant exposure is achieved to impart said characteristic smell,
wherein said combined irradiation subjects said fabric article to a predetermined radiant exposure in a particular time order for a first and second specified time interval,
wherein the interior of the enclosure comprises a plurality of UV-reflective surfaces that have a UV-reflectivity of 80% or more, and
wherein the intensity ratio between ultraviolet light with a wavelength between 280 nm and 320 nm and ultraviolet light with a wavelength between 320 nm and 400 nm, is between 1:4 and 1:30
wherein said overall predetermined radiant exposure is at least 18 kJ/m2.
US Pat. No. 10,244,770

METHOD FOR PRODUCING DRIED FOOD

NISSIN FOODS HOLDINGS CO....

1. A method for producing meat-based dried food that is to be reconstituted by pouring hot or cold water thereto before eating, comprising;processing a meat with superheated steam;
adding additional moisture to the meat processed with superheated steam;
freezing the moisture-added meat; and
drying the frozen meat under reduced pressure.
US Pat. No. 10,245,282

COMPOSITIONS FOR SENSITIVE SKIN

MARY KAY INC., Addison, ...

1. A method of treating erythemic skin of a human in need thereof, the method comprising topically applying to the erythemic skin of said human in need thereof a composition comprising a therapeutically effective amount of:(a) hydrolyzed algin;
(b) escin;
(c) Ruscus aculeatus root extract;
(d) ammonium glycyrrhizate;
(e) Centella asiatica extract;
(f) hydrolyzed yeast protein; and
(g) Calendula officinalis flower extract.
US Pat. No. 10,246,562

PLASTICS COLOURATION

DATALASE LTD., Cheshire ...

1. A method of imparting colour to a plastic substrate, wherein the plastic substrate is selected from packaging, product wrapping films, and melt spun fibres, wherein the plastic substrate is polycaprolactone (PCL) or low density polyethylene (LDPE), wherein said method comprises applying to the substrate, or incorporating within the substrate, a diacetylene compound of general formula (I)R1Q1-C(?O)—(CH2)n—C?C—C?C—(CH2)n—C(?O)-Q1R1  (I)
wherein
n =1 to 20;
Q1=NH or NR3,
R3 is an optionally substituted C1-20 alkyl group which may contain heteroatoms; and irradiating the substrate to impart colour to the substrate;
wherein R1 is a saturated aliphatic hydrocarbon group having a chain length of 8 to 20 carbon atoms,
wherein the diacetylene compound is initially applied to the plastic substrate or incorporated within the plastic substrate in an inactive form, and is subsequently activated by an activating stimulus, prior to being irradiated to impart colour to the plastic substrate,
wherein the activating stimulus is selected from heat at a temperature about or above the melting point of the diacetylene compound and near-infrared light in a wavelength range of 700 nm to 2500 nm, and
wherein, when the activating stimulus is near-infrared light, the plastic substrate further comprises a near-infrared light absorbing agent.
US Pat. No. 10,246,818

COATED NON-WOVEN FABRICS FROM INORGANIC FIBERS AND FUNCTIONAL, DECORATIVE LAYERS FOR FLOOR COVERINGS, CEILING COVERINGS AND WALL COVERINGS MANUFACTURED THEREFROM

Johns Manville, Denver, ...

1. A method for the production of a coated non-woven fabric, the method comprising:supplying a non-woven fabric made of inorganic fibers, the non-woven fabric having a thickness of at least 0.2 mm;
producing a first coating through application of a first suspension comprising a plurality of first particles, the plurality of first particles having a median particle size between 50 and 100 ?m; and
producing a second coating onto the first coating through application of a second suspension comprising a plurality of second particles, the plurality of second particles having a particle size D90 smaller than 20 ?m;
wherein:
the first coating is produced by means of forceless application methods,
the first suspension comprises a plurality of third particles,
the third particles have an aspect ratio of more than 100:1, and
the third particles are platelet-shaped.
US Pat. No. 10,244,771

NON-CRISPR-MEDIATED PHAGE RESISTANT STREPTOCOCCUS THERMOPHILUS

DSM IP ASSETS B.V., Heer...

1. A method for the isolation of bacteriophage-insensitive mutants from a Streptococcus thermophilus parent strain comprising:a. inactivating the CRISPR resistance mechanism of the parent strain;
b. exposing the parent strain obtained in step a. to a bacteriophage to obtain bacteriophage insensitive mutants;
c. isolating the bacteriophage insensitive mutants;
d. comparing the CRISPR loci of the parent strain with the CRISPR loci of the bacteriophage insensitive mutants; and
e. selecting bacteriophage-insensitive mutants of which the CRISPR loci is identical to the CRISPR loci of the parent strain.
US Pat. No. 10,245,283

COMPOSITIONS AND METHODS TO AFFECT SKIN IRRITATION

ALUMEND, LLC, Sioux Fall...

1. A sunscreen composition comprising: (a) at least one sunscreen agent that causes skin irritation and/or skin inflammation and/or IL-1? secretion, and (b) at least one chitosan covalently modified with an octane sulfonic acid via a sulfonamide linkage, wherein the composition provides a reduction in skin irritation and/or a reduction in skin inflammation and/or a reduction in irritant-induced IL-1? secretion after contact with the composition compared with a control composition comprising the sunscreen agent but not the chitosan.
US Pat. No. 10,245,795

COAGULANT AND TIRE PUNCTURE REPAIR KIT

The Yokohama Rubber Co., ...

1. A tire puncture repair kit comprising: a coagulant comprising an ?-starch and a dextrin having a weight average molecular weight of 3,000 to 50,000; and a tire puncture repair liquid.
US Pat. No. 10,246,819

COMPOSITIONS AND METHODS FOR REVERSIBLY DYEING SOFT CONTACT LENSES AND MEDICAL EXAMINATION THEREFROM

1. A method for examining an eye via a hydrogel or silicon hydrogel substrate, comprising:a) immersing a hydrogel or silicon hydrogel substrate in a saline solution outside the eye, wherein the hydrogel or silicon hydrogel substrate has a non-dyed appearance, wherein the hydrogel or silicon hydrogel substrate is a soft contact lens;
b) adding a dye to the saline solution to produce a combination solution;
c) allowing the hydrogel or silicon hydrogel substrate to remain in the combination solution for an amount of time at a temperature from about 60.degree. F. to about 82.degree. F., wherein the dye does not print color into any part of the soft contact lens matrix; and
d) examining the internal and external pathology of an eye by placing on the cornea of the eye the reversibly dyed contact lens and illuminating the inside and the outside of the eye with ultraviolet radiation, removing the ultraviolet radiation and examining the retina, sclera and surrounding tissues of the eye for a corneal abrasion or for a small particle in the eye via a luminescent radiation stored only in the contact lens.
US Pat. No. 10,245,284

GRANULAR COMPOSITION FOR ORAL ADMINISTRATION

ALPEX PHARMA S.A., Mezzo...

1. A granular composition in the form of an oral suspension in water comprisinga non soluble resin selected from the group consisting of Sevelamer carbonate, Sevelamer hydrochloride, and Cholestyramine, and
a highly porous silica gel having a mesoporous structure,
wherein the highly porous silica gel is in the range of 0.1%-5% (w/w).
US Pat. No. 10,246,821

IN-LINE DIGITAL PRINTING SYSTEM FOR TEXTILE MATERIALS

Kornit Digital Ltd., Ros...

1. A digital inkjet printing system for digitally printing an image onto a substrate, comprising at least one inkjet printhead for applying a digital ink, and at least one applicator for applying a base application, said digital ink and said base application being kept separate from each other until discharged toward or upon a receiving surface of the substrate, wherein said base application comprises:between about 30% to about 70% by weight of an aqueous acrylic latex material;
between about 2.5% to about 20% by weight of one or more acrylic resin dispersions;
between about 5% to about 20% by weight of one or more coalescing agents; and
between about 0 to about 40% by weight of a pigment dispersion, said one or more acrylic resins are separate from said latex material, and said acrylic latex material is characterized by a minimum film-forming temperature that ranges from ?10° C. to 50° C.
US Pat. No. 10,245,286

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND VASCULOGENESIS

SanBio, Inc., Mountain V...

1. A method for treating an ischemic disorder in a subject, wherein the ischemic disorder occurs outside the central nervous system, the method comprising:administering, to a site of ischemic disorder in the subject that is outside the central nervous system, a therapeutically effective amount of cells, wherein the cells are made by a method comprising:
(a) providing a culture of mesenchymal stem cells,
(b) contacting the cell culture of step (a) with a polynucleotide comprising sequences encoding a Notch intracellular domain (NICD) wherein said polynucleotide does not encode a full-length Notch protein,
(c) selecting cells that comprise the polynucleotide of step (b), and
(d) further culturing the selected cells of step (c) in the absence of selection and in the absence of trophic factors;
wherein the cells produce angiogenin, angiopoietin-2 (ANG-2) and heparin-binding epidermal growth factor-like growth factor (HB-EGF) at higher levels than do the mesenchymal stem cells of step (a).
US Pat. No. 10,246,566

POLYETHYLENE POLYMER POWDER AND METHOD OF PRODUCING SAME

ASAHI KASEI KABUSHIKI KAI...

1. A polyethylene polymer powder comprising an ethylene homopolymer or a copolymer of ethylene and an ?-olefin having a carbon number of at least 3 and not more than 8, whereinthe polyethylene polymer powder has an intrinsic viscosity IV of at least 12 dL/g and not more than 35 dL/g as measured at 135° C. in decalin solvent,
the polyethylene polymer powder has a melting peak full width at half maximum of at least 2° C. and not more than 7° C. as measured by differential scanning calorimetry at a heating rate of 10° C./min,
the polyethylene polymer powder has a span of at least 0.9 and not more than 2 as determined by laser particle size distribution measurement in methanol, and
the polyethylene polymer powder has an ?-olefin content of 0 mol % to not more than 1.50 mol % as measured by 13C-NMR.
US Pat. No. 10,246,822

TEXTILE PRINTING PAPER FOR USE IN PAPER PRINTING METHOD

MITSUBISHI PAPER MILLS LI...

1. A textile printing paper comprising:a base paper and a glue layer on a surface of the base paper, wherein
the base paper has a swelling rate of 130 to 180% by mass, and
dye fixing treatment is performed on the textile printing paper in such a state that a printed paper is kept stuck to a printing substrate.
US Pat. No. 10,245,287

COMPOSITIONS COMPRISING BACTERIAL STRAINS

4D Pharma Research Limite...

1. A pharmaceutical composition that comprises:a bacteria strain that comprises a 16s rRNA gene sequence with at least 99.5% sequence identity to the polynucleotide of SEQ ID NO:2, wherein the sequence identity is determined by the Smith-Waterman homology search algorithm using an affine gap search with a gap open penalty of 12 and a gap extension penalty of 2, and a BLOSUM matrix of 62; and
a pharmaceutically acceptable excipient, diluent, or carrier;
wherein said bacteria strain has a carbohydrate fermentation profile that comprises:
(i) a positive fermentation of at least one of: L-arabinose and D-xylose; and
(ii) an intermediate fermentation of Methyl-?D-glycopyranoside;
and wherein said bacteria strain is lyophilized.
US Pat. No. 10,246,567

POLYOLEFIN MICROPOROUS FILM

ASAHI KASEI E-MATERIALS C...

1. A biaxially stretched polyolefin microporous film, having a compression elastic modulus of 0.1 to 50 kPa, and a ratio of a tensile elastic modulus in a longitudinal direction to a tensile elastic modulus in a transverse direction of 1.5 to 7.8, whereina tensile strength at break in the transverse direction of the biaxially stretched polyolefin microporous film is 50 MPa or more and 500 MPa or less,
an average pore diameter of the polyolefin microporous film is 0.06 to 0.09 ?m, and wherein an air permeability of the biaxially stretched polyolefin microporous film is in the range of 10 sec/100 cc to 500 sec/100 cc.
US Pat. No. 10,244,776

GRANULATED FEED PHOSPHATE COMPOSITION INCLUDING FEED ENZYMES

The Mosaic Company, Plym...

1. A method of preparing a granular phosphate additive to be added as a component in an animal feed formulation, the method comprising:forming a slurry of a phosphate source, wherein the phosphate source has a phosphorous content of at least 18%; and
co-granulating the slurry with a feed enzyme to form a plurality of granules, each of the plurality of granules containing the feed enzyme.
US Pat. No. 10,245,288

METHOD AND SYSTEM FOR REDUCING THE LIKELIHOOD OF DEVELOPING NASH IN AN INDIVIDUAL DIAGNOSED WITH NON-ALCOHOLIC FATTY LIVER DISEASE

1. A method for reducing the likelihood of developing non-alcoholic steatohepatitis (NASH) in an individual diagnosed with non-alcoholic fatty liver disease, comprising: providing in the gut of an individual a population of beneficial bacteria selected from the group consisting of Lactobacillus species; administering at least 6 grams per day of fiber to the individual to maintain a therapeutically effective amount of the beneficial bacteria in the gut of the individual; and inhibiting monoacylglycerolacyltransferase-3 (MGAT3) synthesis in the individual to lower triacylglycerol (TAG) production.
US Pat. No. 10,244,777

PALATABLE EXPANDED FOOD PRODUCTS AND METHODS OF MANUFACTURE THEREOF

BIG HEART PET, INC., Orr...

1. A pet food product comprising:an expanded matrix comprising:
a skeletal structure comprising starch from 75 to about 95% by weight of said skeletal structure, and
a plurality of intercommunicated pores defined by surfaces of said skeletal structure and dispersed throughout said expanded matrix and partially exposed through an outer surface of said expanded matrix;
fat infused in a substantial amount of said pores from about 10 to about 45% by weight of said pet food product; and
a coating on at least said surface of said expanded matrix from about 20 to about 45% by weight or less of said pet food product.
US Pat. No. 10,245,289

TREATMENT AND PROPHYLAXIS FOR LUPUS

NuBiome, Inc., Mountain ...

1. A method of mitigating or treating Lupus comprises:administering an effective amount of a medicament to the gastrointestinal tract of a human comprised of Lactobacillus bulgaricus B-30892 and/or a supernatant resulting from culturing Lactobacillus bulgaricus B-30892 and/or bioactive materials resulting from culturing Lactobacillus bulgaricus B-30892 to mitigate or treat Lupus.
US Pat. No. 10,246,569

RECYCLING OF FIBROUS SURFACE COVERINGS

GEO-TECH POLYMERS, LLC, ...

1. A process mixture, comprising:a fibrous surface covering in contact with a single phase aqueous solution;
the fibrous surface covering comprising:
a fibrous surface layer;
a first backing coupled to the fibrous surface layer;
a binder coupled to one or more of the first backing and the fibrous surface layer; and
the single-phase aqueous solution comprising:
water;
a surfactant composition, the surfactant composition consisting essentially of one or more alkyl polyglycosides in a weight percentage (w/w) with respect to the water of about 0.01% to 0.5%;
an inorganic base composition;
a stable peroxygen composition; and
a monosaccharide salt,the process mixture characterized by a pH value of about 10 to about 14.
US Pat. No. 10,245,290

PROBIOTIC STRAINS FOR USE IN TREATMENT OR PREVENTION OF OSTEOPOROSIS

Probi AB, Lund (SE)

1. A method for treating or inhibiting osteoporosis, treating or inhibiting bone loss, or increasing the absorption of Ca2+ ions, comprising orally administering to a mammal a composition comprising a therapeutically effective amount of at least one probiotic strain selected from the group consisting of Lactobacillus paracasei 8700:2, DSM 13434, and Lactobacillus paracasei 02:A, DSM 13432, wherein the composition is supplemented with additional Ca2+ in the form of a salt, wherein the inhibition of osteoporosis or bone loss is by reducing osteoporosis or bone loss compared to osteoporosis or bone loss without administration of said composition, and wherein increasing the absorption of Ca2+ ions is compared to absorption of Ca2+ ions without administration of said composition.
US Pat. No. 10,246,570

THERMOPLASTIC RESIN COMPOSITION HAVING EXCELLENT LIGHT STABILITY AT HIGH TEMPERATURE

Lotte Advanced Materials ...

1. A thermoplastic resin composition that can have light stability at a high temperature comprising: (A) a polyester resin prepared by polycondensation of an aromatic dicarboxylic acid component and a diol component including an alicyclic diol; (B) a white pigment; and (C) a sodium phosphate salt, wherein the composition includes sodium in an amount of about 0.01 to about 3 wt % based on the total weight of the composition, wherein a molded product prepared from the composition has an initial reflectance measured at a wavelength of about 450 nm using a colorimeter of about 90% or more, and a reflection decrease rate measured after exposure to a white light emitting diode (LED) light source at 105° C. for 500 hours of less than about 30%.
US Pat. No. 10,245,291

LIPID METABOLISM AND/OR SUGAR METABOLISM IMPROVER CONTAINING LACTIC ACID BACTERIUM OR TREATMENT PRODUCT THEREOF

Asahi Group Holdings, Ltd...

1. A method for improving lipid metabolism and/or sugar metabolism in a subject in need thereof, comprising administering an effective amount of a lactic acid producing bacterium, a treated product thereof, or a mixture thereof to the subject, thereby improving lipid metabolism and/or sugar metabolism in the subject,wherein the effective amount corresponds to about 105 cells/gram to about 1014 cells/gram of the lactic acid producing bacterium;
wherein the lactic acid producing bacterium is Lactobacillus amylovorus CP1563 strain (Accession Number FERM BP-11255), Lactobacillus amylovorus CP1562 strain (Accession Number FERM BP-11379), or a mutant or bred strain thereof;
wherein the lactic acid producing bacterium has dual-agonistic activities on a peroxisome proliferator activated receptor (PPAR)? and a peroxisome proliferator activated receptor (PPAR)?, wherein(a) the PPAR? agonistic activity is about 70% or more of the PPAR? agonistic activity of a positive control, as measured by a PPAR? reporter assay; and(b) the PPAR? agonistic activity is about 30% or more of the PPAR? agonistic activity of a positive control, as measured by a PPAR? reporter assay.
US Pat. No. 10,245,547

SULFUR REMOVAL SYSTEM

King Fahd University of P...

1. A sulfur removal system, comprising:a first reactor comprising
a first vessel having a first internal cavity with a first adsorbent bed that contains a first adsorbent,
a first inlet located proximal to a bottom of the first vessel, and
a first outlet located proximal to a top of the first vessel;
wherein the first reactor is a fluidized-bed reactor; and
a second reactor comprising
a second vessel having a second inlet, a second outlet, and a second internal cavity with a second adsorbent bed that contains a second adsorbent,
wherein the first and the second adsorbents comprise cobalt and copper on an activated carbon support,
wherein the first adsorbent bed has a cross-sectional area that is substantially the same as a cross-sectional area of the first vessel, and
wherein the second inlet is fluidly connected to the first outlet via a connecting line.
US Pat. No. 10,245,292

COMPOSITION FOR ENHANCING MALE SEX HORMONE AND MEN'S HEALTH

FAMENITY CO., LTD, Gwach...

1. A method of reducing the instance of, improving, or treating male climeractic disorder and symptoms thereof comprising:administering an effective amount of a composition comprising a dandelion extract and a rooibos extract to a subject with male climeractic disorder, wherein the dandelion and rooibos extracts are obtained by extraction with a solvent selected from the group consisting of water, alcohol, and a mixture thereof; wherein the weight ratio of the dandelion extract and the rooibos extract is 4:1-1:9; and wherein the amount of the dandelion extract, or dandelion extract and rooibos extract, administered is from 0.01 mg/day/kg to 100 mg/day/kg of body weight.
US Pat. No. 10,246,572

FOAMABLE FLUOROPOLYMER COMPOSITIONS

SOLVAY SPECIALTY POLYMERS...

1. A foamable thermoplastic fluoropolymer composition comprising:at least one melt-processible fluoropolymer [polymer (A)]; and
at least one perfluoroalkoxysulphonic derivative selected from the following compounds:
CF3—(CF2)w—OCF2CF2—SO3?(Zp+)1/p  (i)
wherein w is an integer from 1 to 3, Z is NH4 or an alkaline or alkali-earth metal cation, and
p is the valence of the cation Z;
CF3—(CF2)w?OCF2CF2—OCF2CF2—SO3?(Zp+)1/p  (ii)
wherein w? is an integer from 0 to 2, Z is NH4 or an alkaline or alkali-earth metal cation, and
p is the valence of the cation Z; and
CF3—(CF2)q—(OCF2CFXF)r—OCF2CF2—SO3?(Zp+)1/p  (iii)
wherein q and r are each independently an integer from 1 to 3, XF is F or CF3, Z is NH4 or an alkaline or alkali-earth metal cation, and p is the valence of the cation Z.
US Pat. No. 10,245,293

PET FOOD SUPPLEMENT

Vetnique Labs LLC, Naper...

1. A method of treatment or prevention of anal gland disease, the method comprising administering to a subject in need of such treatment an effective amount of one or more compositions comprising (1) a probiotic, a prebiotic, or both, (2) a fiber source, and (3) an anti-inflammatory agent selected from the group consisting of fish oil, bioflavonoid, bromelain, Vitamin C, Vitamin E, L-glutathione, selenium, resveratrol, papain, flax seed oil, curcumin, ginger, alpha lipoic acid, zinc, quercetin, and a combination thereof.
US Pat. No. 10,246,829

COATING OF COMPOSITE WOOD PANELS WITH AMINOPLAST RESIN FILMS FITTED WITH AN ABRASION-RESISTANT, EASY-CLEAN AND HYDROPHOBIC SURFACE

HUECK Rheinische GmbH, V...

1. A method comprising:providing decorative and/or overlay papers,
impregnating the decorative and/or overlay papers with aminoplast resin to form impregnated papers,
after the impregnation, coating the impregnated papers with a sol-gel preparation comprising:
dissolved metal alkoxides,
fullerene-like nanostructures made of metal disulfides of molybdenum and/or tungsten, and
fullerene-like nanotubes made of metal disulfides of molybdenum and/or tungstensuch that coated papers are formed,drying the coated papers to form dried papers, and
pressing the dried papers in a hydraulic heating press such that the dried papers are condensed and such that an abrasion-resistant, hydrophobic surface is formed on the dried papers so that finished papers are formed.
US Pat. No. 10,244,782

SWEETENER COMPOSITIONS AND FOODS, BEVERAGES, AND CONSUMABLE PRODUCTS MADE THEREOF

DOUXMATOK LTD, Tel-Aviv ...

1. A sweetener composition comprising one or more sweetener carbohydrates, wherein the one or more sweetener carbohydrates are selected from the group consisting of sucrose, glucose, fructose, maltose, lactose, high fructose corn syrup, high maltose corn syrup, and a combination thereof, and 0.05-4% carrier compound weight/weight relative to a sum of total sweetener carbohydrate; wherein the sweetener composition is made by mixing the one or more sweetener carbohydrates with a carrier compound precursor and a catalyst such that a reaction between the carrier compound precursor and the catalyst occurs in the presence of the one or more sweetener carbohydrates to form the sweetener composition; wherein the sweetener composition has enhanced sweetness compared to a control composition; wherein the carrier compound is silica; and wherein the control composition consists of the same contents by identity and quantity as the one or more sweetener carbohydrates.
US Pat. No. 10,245,294

DIETARY SUPPLEMENT

GRATUK TECHNOLOGIES PTY L...

1. A method of treatment of the effects of chronic inflammation and associated conditions in an individual by feeding to said individual a food product incorporating dietary fibre material derived from whole sugar cane, whole sweet sorghum or whole bamboo; said dietary fibre material having been prepared according to a method including the steps of:subjecting the dietary fibre material to at least one wet diffusion step at neutral pH and a temperature is in the range of 25° C. to 70° C., to separate unwanted macronutrients including carbohydrates, fats and proteins, from a residual fibre material of the dietary fibre material whilst maintaining bioactive micro-nutrient content including polyphenolic antioxidants and flavonoid antioxidants; and
subjecting the residual fibre material to a drying process that does not induce significant breakdown of the bioactive micronutrients retained by the chemical free extraction.
US Pat. No. 10,246,574

LIGHT REFLECTIVE PARTS AND REFLECTIVE PARTS FOR AUTOMOBILE LAMP

ASAHI KASEI KABUSHIKI KAI...

1. A light reflective part comprising a polyphenylene ether resin composition containinga polyphenylene ether (A), and
9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide or a derivative thereof (B), wherein
the (A) component has a content of from 95 mass % to 99.95 mass % and the (B) component has a content of from 0.05 mass % to 5 mass % relative to 100 mass %, in total, of the (A) component and the (B) component, and wherein
the polyphenylene ether resin composition is free of a sulfur-containing antioxidant.
US Pat. No. 10,245,295

NEUROLOGICAL ESSENTIAL OIL COMPOSITION AND METHODS

Laura Harris Smith

1. A composition of eight essential oils containing sesqiterpene compounds as active ingredients for therapeutic relief of neurological ailments, said composition comprising 2-18% oil from the grasses of Vetiveria zizanioides, 7-23% oil from the flowers of Cananga odorata, 7-23% oil from the wood of Santalum spicatum trees, 11-27% oil from the leaves of Pogostemon cablin, 5-31% oil from the wood of Juniperus virginiana, 7-23% oil from the resin of Commiphora myrrha, oil from the resin of Boswellia carterii trees, and 5-25% oil from the flowers of Lavandula officinalis.
US Pat. No. 10,246,576

SULFUR-CROSSLINKABLE RUBBER MIXTURE AND MOTOR VEHICLE TIRES

Continental Reifen Deutsc...

1. A sulfur-crosslinkable rubber mixture comprising:from 40 to 100 phr of at least one natural and/or synthetic polyisoprene;
15 phr or more of at least one hydrocarbon resin which is built up to the extent of 50 to 100 wt. % from aliphatic C5 monomers and to the extent of 0 to 50 wt. % from further monomers, wherein the hydrocarbon resin according to formula I) has a Q of from 0.015 [° C.·mol/g] to 0.050 [° C.·mol/g], wherein formula I) is defined as Q=softening point [° C.]/centrifuge average Mc [g/mol]; and,
70 to 250 phr of at least one silica;wherein, after vulcanization, the sulfur-crosslinkable rubber mixture has an elongation at break of from 651% to 722% at room temperature, in accordance with DIN 53 504.
US Pat. No. 10,245,297

INHIBITORS OF MITOCHONDRIAL FISSION AND METHODS OF USE THEREOF

The Board of Trustees of ...

1. A peptide consisting of (i) YGRKKRRQRRR (SEQ ID NO: 31), (ii) GG and (iii) DLLPRGS (SEQ ID NO: 12) attached in the order (i), (ii), and (iii) from amino terminus to carboxyl terminus, or a pharmaceutically acceptable salt thereof, wherein the carboxyl terminus of the peptide or pharmaceutically acceptable salt thereof is optionally chemically modified by amidation.
US Pat. No. 10,246,577

TIRE PROVIDED WITH A TREAD COMPRISING A RUBBER COMPOSITION INCLUDING A THERMOPLASTIC RESIN OF POLY(METHYL METHACRYLATE)

COMPAGNIE GENERALE DES ET...

1. A tire provided with a tread comprising a rubber composition based on at least one diene elastomer, a reinforcing filler, a crosslinking system and a polymethyl methacrylate thermoplastic resin, the polymethyl methacrylate thermoplastic resin exhibiting a Vicat softening point, measured according to Standard ISO 306: 2013 B50, within a range extending from 60° C. to 100° C.
US Pat. No. 10,245,298

COMPOSITIONS AND METHODS FOR TREATING FIBROSIS

Cedars-Sinai Medical Cent...

1. A pharmaceutical composition comprising: a IL-4/IL-13 receptor inhibitor; and (ii) a pharmaceutically acceptable carrier, wherein the IL-4/IL-13 receptor inhibitor is CSRM53567 comprising of the amino acid sequence Tyr-Cys-Asp-Asp-Phe-Val-Gly-Ser-Phe-Asp-Cys-Tyr (SEQ ID NO: 1).
US Pat. No. 10,246,578

COMPOSITE MATERIAL FROM WASTE AND AT LEAST ONE ELEMENT OF VULCANIZED RUBBER AND TIRE CORDS

UBQ Materials Ltd., Peta...

1. A process comprising:extruding a first component comprising organic waste and thermoplastic waste with a second component comprising vulcanized rubber and optionally tire cords to obtain a melt;
processing the melt, the processing comprises at least cooling the melt to obtain a composite material, the composite material comprising:
a non-plastic organic element;
a thermoplastic element; and
at least one element comprising vulcanized rubber and optionally tire cords;
wherein an amount by weight of the non-plastic organic element is at least 10% w/w out of a total weight of a combined amount of the first component and the second component;
wherein an amount by weight of the thermoplastic element is up to 40% w/w out of the total weight of the combined amount of the first component and the second component; and
wherein an amount by weight of the vulcanized rubber is at least 40% w/w out of the total weight of the combined amount of the first component and the second component.
US Pat. No. 10,245,299

AUTOASSEMBLING PEPTIDES FOR THE TREATMENT OF PULMONARY BULLA

3-D Matrix, Ltd., Tokyo ...

1. A method of treating a pulmonary bulla in a subject, comprising:introducing a delivery device to a target area of the pulmonary bulla of the subject;
positioning an end of the delivery device in the target area in which a treatment of the pulmonary bulla is desired;
administering, through the delivery device, a solution comprising an amphiphilic self-assembling peptide comprising between about 7 amino acids and 32 amino acids in an effective amount and in an effective concentration to the target area to form a hydrogel barrier under physiological conditions of the target area to treat the pulmonary bulla;
removing the delivery device from the target area; and
collapsing the pulmonary bulla prior or subsequent to administering the solution.
US Pat. No. 10,245,811

SURFACE-PROTECTING FILM

KURARAY CO., LTD., Kuras...

1. A surface protective film, comprising:a polyolefin-based substrate layer and
a pressure-sensitive adhesive layer,
wherein:
the pressure-sensitive adhesive layer comprises:
a styrene-based elastomer,
an acrylic-based pressure-sensitive adhesive, and
a tackifier, and
in the pressure-sensitive adhesive layer,
the styrene-based elastomer is blended in an amount of not less than 50% by mass but not more than 90% by mass based on the total amount of the pressure-sensitive adhesive layer,
the acrylic-based pressure-sensitive adhesive is blended in an amount of not less than 1% by mass but not more than 40% by mass based on the total amount of the pressure-sensitive adhesive layer, and
the tackifier is blended in an amount of not less than 1% by mass but not more than 49% by mass based on the total amount of the pressure-sensitive adhesive layer,
the acrylic-based pressure-sensitive adhesive comprises, as a constituent, a polymer of a structure represented by formula (3),
[C-D-C]n  (3),
wherein C represents a polymer block C,
D represents a polymer block D, and
n represents an integer of 1 to 3,
the polymer block C is a polymer block composed of continuous methacrylic ester units, and
the polymer block D is a polymer block composed of continuous acrylic ester units.
US Pat. No. 10,246,579

THERMOPLASTIC COMPOSITION COMPRISING POLYETHYLENE, MANUFACTURE AND USE THEREOF

AUTONEUM MANAGEMENT AG, ...

1. A thermoplastic composition, comprising:from 10 to 50% by weight of a combination of at least one first ethylene polymer, at least one second ethylene polymer, and at least one third ethylene polymer,
wherein the first ethylene polymer has the following properties:
a density in the range of 0.87 g/cm3 to 0.90 g/cm3;
a melt flow index in the range of 0.3 g/10 min to 5 g/10 min; and
a flexural modulus in the range of 5 MPa to 60 MPa;
wherein the second ethylene polymer has the following properties:
a density in the range of 0.90 g/cm3 to 0.92 g/cm3;
a melt flow index in the range of 0.3 g/10 min to 10 g/10 min; and
a flexural modulus which is higher than that of the first ethylene polymer; and
wherein the third ethylene polymer has the following properties:
a density in the range of 0.92 g/cm3 to 0.97 g/cm3; and
a melt flow index in the range of 15 g/10 min to 100 g/10 min;
from 35 to about 90% by weight of inorganic particles as filler; and
from 0.05 to 20% by weight of a liquid (at 23° C.) which acts as a plasticizer for at least one of the at least one first ethylene polymer, the at least one second ethylene polymer, and the at least one third ethylene polymer; and
wherein each density is determined according to ASTM D792, each melt flow index is determined according to ASTM D1238, at 190° C. and 2.16 kg, and each flexural modulus is determined according to ASTM D790.
US Pat. No. 10,249,396

METHOD FOR THE TREATMENT OF AN AQUEOUS NITRIC SOLUTION RESULTING FROM DISSOLVING SPENT NUCLEAR FUEL, SAID METHOD BEING PERFORMED IN A SINGLE CYCLE AND WITHOUT REQUIRING ANY OPERATION INVOLVING REDUCTIVE STRIPPING OF PLUTONIUM

ORANO CYCLE, Courbevoie ...

1. A method for processing in one cycle an aqueous solution resulting from a dissolution of a spent nuclear fuel in nitric acid, the aqueous solution comprising uranium, plutonium, americium, curium and fission products including technetium, the cycle comprising:a) a co-extraction of uranium and plutonium from the aqueous solution, the co-extraction comprising at least one contacting, in an extractor, of the aqueous solution with a first organic solution comprising from 1 mol/L to 2 mol/L of N,N-di(2-ethylhexyl)-3,3-dimethylbutanamide or a mixture of N,N-di(2-ethylhexyl)-isobutanamide and N,N-di(2-ethylhexyl)-n-butanamide as extractant, in solution in an organic diluent, followed by a separation of the aqueous solution from the organic solution;
b) a decontamination of the organic solution resulting from a) with respect to americium, curium and fission products, the decontamination comprising at least one contacting, in an extractor, of the organic solution resulting from a) with an aqueous solution comprising from 0.5 mol/L to 6 mol/L of nitric acid, followed by a separation of the organic solution from the aqueous solution;
c) a partitioning of the uranium and plutonium contained in the organic solution resulting from b) into an aqueous solution and an organic solution, the aqueous solution comprising either plutonium without uranium, or a mixture of plutonium and uranium, and the organic solution comprising uranium without plutonium, the partitioning comprising:
c1) a stripping of plutonium, in oxidation state +IV, and of a fraction of uranium from the organic solution resulting from b), the stripping comprising at least one contacting, in an extractor, of the organic solution resulting from b) with an aqueous solution comprising from 0.1 mol/L to 0.5 mol/L of nitric acid, followed by a separation of the organic solution from the aqueous solution;
c2) an extraction of all or part of the uranium fraction contained in the aqueous solution resulting from c1), the extraction comprising at least one contacting, in an extractor, of the aqueous solution resulting from c1) with a second organic solution identical to the first organic solution, followed by a separation of the aqueous solution from the second organic solution;
d) a decontamination of the organic solution resulting from c1) with respect to technetium, the decontamination comprising:
d1) a stripping of technetium, in oxidation state +IV, from the organic solution resulting from c1), the stripping comprising at least one contacting, in an extractor, of the organic solution resulting from c1) with an aqueous solution comprising from 0.1 mol/L to 3 mol/L of nitric acid and at least one reducing agent capable of reducing technetium from oxidation state +VII to oxidation state +IV, or a complexing agent capable of stabilising technetium in aqueous phase, followed by a separation of the organic solution from the aqueous solution;
d2) an extraction of the uranium fraction contained in the aqueous solution resulting from d1), the extraction comprising at least one contacting, in an extractor, of the aqueous solution resulting from d1) with a third organic solution identical to the first organic solution, followed by a separation of the aqueous solution from the third organic solution;
e) a stripping of uranium from the organic solution resulting from d1), the stripping comprising at least one contacting, in an extractor, of the organic solution resulting from di) with an aqueous solution comprising no more than 0.05 mol/L of nitric acid, followed by a separation of the organic solution from the aqueous solution; and
f) a regeneration of the organic solution resulting from e);whereby a first and second aqueous solution are obtained, decontaminated with respect to americium, curium and fission products including technetium, the first aqueous solution comprising plutonium without uranium or a mixture of plutonium and uranium, and the second aqueous solution comprising uranium without plutonium.
US Pat. No. 10,245,300

GLUTEN-RELATED DISORDERS

H.J. Heinz Company Brands...

1. A method of treating a subject having a gluten-related disorder, the method comprising:administering to the subject an effective amount of a composition comprising a probiotic bacterium Lactobacillus paracasei CBA L74, deposited at the Belgian Coordinated Collections of Micro-organisms (BCCM) Laboratorium voor Microbiologie (LMG) and having International Depository Accession Number LMG P-24778, wherein the probiotic bacterium reduces a symptom of gliadin peptide toxicity.
US Pat. No. 10,245,301

GLYCOSAMINOGLYCANS

Agency for Science, Techn...

1. A method of treatment of injury or disease, the method comprising administering, to an individual in need thereof, a therapeutically effective amount of an isolated or substantially purified heparan sulphate composition comprising a heparan sulphate component, wherein the heparan sulphate component is at least 97% HS/BMP2 which is capable of specific binding to SEQ ID NO:1 or 6, and to BMP2, and which is obtained by a method comprising:(i) providing a solid support having polypeptide molecules adhered to the support, wherein the polypeptide consists of the amino acid sequence QAKHKQRKRLKSSCKRHP [SEQ ID NO:1] or QAKHKQRKRLKSSCKRH [SEQ ID NO:6];
(ii) contacting the polypeptide molecules with a heparan sulphate fraction obtained from mammalian tissue or extracellular matrix such that polypeptide-heparan sulphate complexes are allowed to form;
(iii) partitioning polypeptide-heparan sulphate complexes from the remainder of the mixture;
(iv) dissociating the heparan sulphate from the polypeptide-heparan sulphate complexes by disrupting the polypeptide-heparan sulphate complexes; and
(v) collecting the dissociated heparan sulphate; wherein the method comprises the repair and/or regeneration of bone.
US Pat. No. 10,246,581

RUBBER COMPOSITIONS CONTAINING WHEY PROTEIN

Bridgestone Americas Tire...

1. A rubber composition comprising:a. at least one of a butyl rubber or a halogenated butyl rubber;
b. at least one filler in an amount of about 5 to about 200 phr; and
c. a whey protein component in an amount sufficient to provide about 0.1 to about 10 phr whey protein,
wherein the whey protein meets all of the following:
d. a majority of the protein chains in the whey protein have a molecular weight of greater than about 10 kDaltons;
e. a majority of the proteins in the whey protein are a combination of alpha-lactalbumin and beta-lactoglobulin; and
f. a degree of hydrolysis of less than 50%.
US Pat. No. 10,245,302

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

BRISTOL-MYERS SQUIBB COMP...

1. A nucleic acid encoding a polypeptide comprising a fibronectin type III tenth (10Fn3) domain which binds to myostatin and (i) comprises AB, BC, CD, DE, EF, and FG loops, wherein at least one loop of the BC, DE, and FG loops of the 10Fn3 domain has 0, 1, 2, or 3 amino acid substitutions relative to the respective BC, DE, and FG loops of SEQ ID NOs: 34, 39, and 75.
US Pat. No. 10,246,582

RESIN COMPOSITION AND RESIN MOLDED ARTICLE

ZEON CORPORATION, Chiyod...

1. A resin composition comprising a cycloolefin resin and at least two hydrogenated styrene-based thermoplastic elastomers,wherein a content of the cycloolefin resin is 50 to 90 wt % based on a total amount of the cycloolefin resin and the hydrogenated styrene-based thermoplastic elastomers, and
a melt volume rate of the resin composition at 260° C. is higher than that of the cycloolefin resin at 260° C.
US Pat. No. 10,246,838

HIGH IMPACT JOINT AND CRACK FILLERS

1. A joint and crack filler composition comprising:a rubber aggregate comprising a tri-blend aggregate comprising a mixture of large shreds of rubber, small shreds of rubber, and fine pieces of rubber; and
a binder comprising a resin and a hardener,
wherein:
the large shreds of rubber have a length of from about ½ to about ¾ inch and a width of about 1/16 inch;
the small shreds of rubber have a length of from about ? to about ¼ inch and a width of about 1/16 inch; and
the fine pieces have a US sieve size of from about 60 to 120.
US Pat. No. 10,245,303

COMPOSITIONS AND METHODS FOR ENZYMATIC TREATMENT OF LUNG DISORDERS

Laclede, Inc., Rancho Do...

1. A method of treating a lung disease or condition comprising the step of administering to a patient suffering from the lung disease or condition, a therapeutic composition comprising:(a) a peroxidase enzyme being present in a sufficient quantity such that the biocide is produced in a therapeutically effective concentration;
(b) a salt, wherein the salt is an alkali metal salt of an anion of thiocyanate, iodate and chlorate; and
(c) an aqueous medium in which the peroxidase enzyme and the salt that acts as an oxygen acceptor are stable,wherein the therapeutic composition is administered by a route in which the ingredients of the composition reach the lungs and generate the biocide within the lungs to treat the lung disease or condition.
US Pat. No. 10,245,559

NANOFILTRATION MEMBRANES AND METHODS OF USE

Novomer, Inc., Boston, M...

1. A method of removing catalyst from a process of carbonylating epoxide, comprising:a) contacting epoxide with carbon monoxide in the presence of a homogenous carbonylation catalyst to provide a process stream comprising beta lactone and the homogenous catalyst;
b) flowing the process stream over a nanofiltration membrane to provide a permeate stream comprising beta lactone and a retentate stream comprising homogenous catalyst; and
c) returning the retentate stream to step (a),wherein the concentration of the catalyst in the retentate stream is higher than the catalyst concentration in the permeate stream, andwherein the nanofiltration membrane comprises a polysiloxane polymer, wherein the polysiloxane polymer is treated with a reagent reactive toward —OH groups.
US Pat. No. 10,245,304

TREATMENT OF ALPHA-GALACTOSIDASE A DEFICIENCY

SHIRE HUMAN GENETIC THERA...

1. A kit for the treatment of ?-Gal A deficiency, comprising: (a) a human ?-Gal A glycoprotein preparation; and (b) instructions to administer the preparation to a subject in need thereof, wherein the serum clearance of the ?-Gal A preparation from subject's circulation is less than 4 mL/min/kg on the linear portion of the AUC vs. dose curve, wherein the ?-Gal A glycoprotein preparation has the following four characteristics:(1) has less than 35% tri- and tetra-sialylated glycans combined;
(2) has greater than 50% complex glycans;
(3) has less than 45% phosphorylated glycans; and
(4) has a ratio of sialylated glycans to phosphorylated glycans greater than 1.
US Pat. No. 10,246,584

ADDITIVE TO PREVENT PHASE SEPARATION OF LOW PROFILE ADDITIVE IN UNSATURATED THERMOSET POLYESTER COMPOSITIONS

Lubrizol Advanced Materia...

1. A unsaturated resin molding composition comprisingan additive to prevent phase separation,
an addition polymerized polymer (D) for low profile characterized as having a number average molecular weight above 50,000 g/mole and existing as a dispersed phase in said composition,
a radical copolymerizable unsaturated resin, and
a polymerizable unsaturated monomer,wherein said additive to prevent phase separation comprises a reaction product of a functionalized polyether of a formula:R1—(OC?H2?)x—(OCH2CH2)y—W-?-COOH with an aminic polybasic species having at least 3 primary and/or secondary amine groups per molecule and a number average molecular weight of from 100 to 100,000 g/mole in a weight ratio of said R1—(OC?H2?)x—(OCH2CH2)y—W-?-COOH:aminic polybasic species of 10:1 to 60:1,wherein:R1 is a C1-C36 hydrocarbyl group which can be a cyclic, branched, or non-branched alkyl; aryl; alkylaryl or arylalkyl,
? is 3 and/or 4,
x is 10-60,
y is 0-10,
the —(OC?H2?) and —(OCH2CH2) repeat units can be in any order such as random or blocky and y must be less than x,
W is an ester, imide, or optionally amide linking group that can optionally include a hydrocarbylene of 1-4 carbon atoms,
? is an aryl group of 6-10 carbon atoms and said aryl group can optionally have substituent(s) which include linear or branched alkyl chains of 1-4 carbon atoms, halides, and/or —NO2.
US Pat. No. 10,245,305

BOTULINUM TOXIN THERAPY FOR SKIN DISORDERS

Allergan, Inc., Irvine, ...

1. A method for reducing the occurrence or alleviating a melanin related affliction in a patient in need thereof, the method comprising the step of locally administering a therapeutically effective amount of a botulinum toxin to an area affected by the melanin related affliction, thereby reducing the occurrence or alleviating the melanin related affliction, wherein the melanin related affliction is selected from the group consisting of dermatofibromas, freckles and atypical moles (dysplastic nevi).
US Pat. No. 10,245,817

METHOD OF LAMINATING ABSORBABLE SEMI-CRYSTALLINE POLYMERIC FILMS

Ethicon, Inc., Somervill...

1. A method of making a laminated medical device construct, comprising:a) extruding a polymer film having a semi-crystalline structure and a melting point temperature of 140° or higher, a glass transition temperature below 25° C., and a crystallinity, said polymer film being crystallizable at room/ambient conditions;
b) laminating the polymer film directly to a substrate, said substrate being thermally sensitive and polymeric, to form the laminated medical device construct by conducting a thermal/pressure laminating step within about 10 minutes after the polymer film has been extruded wherein the polymer film has a crystallinity of about 10% or less in order to laminate said polymer film onto a substrate at a temperature of about 120° C. or lower, wherein the substrate is not damaged and the polymer film is effectively laminated to the substrate.
US Pat. No. 10,246,585

POLYORGANOSILOXANE-CONTAINING GRAFT COPOLYMER, THERMOPLASTIC RESIN COMPOSITION, AND MOLDED PRODUCT

Mitsubishi Chemical Corpo...

1. A polyorganosiloxane-containing graft copolymer, which provides a molded product having the following properties described in (1) to (3):(1) a Charpy impact strength at ?30° C. of 20 kJ/m2 or more,
(2) a L* value of 8 or less, and
(3) a flame retardance of V1 or V0;wherein the Charpy impact strength, the L* value, and the flame retardance are measured under the following conditions:preparing test piece 1, test piece 2, and test piece 3, respectively, according to the following manufacturing conditions:manufacturing conditions of the test piece 1 and the test piece 2:
(a) the polyorganosiloxane-containing graft copolymer is 3 parts by mass,
(b) an aromatic polycarbonate resin having a viscosity-average molecular weight of 24,000 is 97 parts by mass,
(c) n-octadecyl-3-(3?,5?-di-tert-butyl-4?-hydroxyphenyl)propionate is 0.1 parts by mass,
(d) tris(2,4-di-tert-butylphenyl)phosphite is 0.1 parts by mass, and
(e) carbon black is 0.1 parts by mass,
where the materials (a) to (e) are prepared, mixed and extruded under a conditions of a screw rotation speed of 150 rpm via a devolatilizing extruder heated to a roller temperature of 280° C. to obtain particles, which are then molded via a 100 t injection molding machine under conditions of a barrel temperature of 280° C. and a mold temperature of 90° C. to obtain the test piece 1 (length: 80 mm, width: 10 mm, thickness: 4 mm, with a V-notch) and the test piece 2 (length: 100 mm, width: 50 mm, thickness: 2 mm);
manufacturing conditions of test piece 3:
(a) the polyorganosiloxane-containing graft copolymer is 5 parts by mass,
(b) an aromatic polycarbonate resin having a viscosity-average molecular weight of 24,000 is 90 parts by mass,
(e) carbon black is 0.1 parts by mass,
(f) flame retardant [(CH3)2C6H3O]2P(O)OC6H4OP(O)[OC6H3(CH3)2]2 is 5 parts by mass,
(g) a polytetrafluoroethylene-containing powder is 1 part by mass,
where the materials (a), (b), (e), (f), and (g) are prepared, mixed and extruded under a conditions of a screw rotation speed of 150 rpm via a devolatilizing extruder heated to a roller temperature of 280° C. to obtain particles, which are then molded via a 100 t injection molding machine under conditions of a barrel temperature of 280° C. and a mold temperature of 90° C. to obtain the test piece 3 (length: 127 mm, width: 12.7 mm, thickness: 1.6 mm);
measurement conditions of Charpy impact strength:
measure the Charpy impact strength of the test piece 1 placed in an environment of ?30° C. for 12 hours or more according to a method of International Standard Organization 179;
measurement conditions of L* value:
measure tristimulus values (XYZ) of the test piece 2 according to the measurement conditions of Japanese Industrial Standard Z8722, and then calculate a L* value using an International Commission on Illumination color difference formula,
where the measurement is conducted on a spectroscopic colorimeter using a method of after-sample light splitting of 0° to 45°, with a measurement range of 380 nm to 780 nm, and a C light (2° field of view) as a measurement light source;
measurement conditions of flame retardance:
measure the flame retardance of the test piece 3 according to UL-94V (vertical flame test).
US Pat. No. 10,245,306

FLEXIBLE TISSUE MATRIX AND METHODS FOR JOINT REPAIR

ISTO TECHNOLOGIES II, LLC...

1. A tissue matrix for supporting repair of biological tissues comprising total polymers comprising a caprolactone polymer and at least one additional polyester polymer other than a caprolactone polymer which is not copolymerized with the caprolactone polymer, wherein the total polymers are entangled with a polysaccharide following combination of the total polymers and the polysaccharide in a dual solvent emulsion, said dual solvent emulsion being formed by the steps of:i. dissolving the total polymers in an organic solvent;
ii. dissolving the polysaccharide in an aqueous solvent;
iii. blending the total polymers in the organic solvent with the polysaccharide in an aqueous solvent to form the dual solvent emulsion; and
iv. removing the organic solvent and aqueous solvent from the emulsion to form a flexible matrix comprising the total polymer molecules entangled with polysaccharide polymer molecules;
wherein the weight ratio of the polyester polymer to the caprolactone polymer ranges from about 1:1 to about 4:1.
US Pat. No. 10,246,586

LIGHT-RESISTANCE IMPROVER

DAICEL-EVONIK LTD., Toky...

1. A method for improving the light resistance of a non-fluorinated thermoplastic resin, which comprises adding a light-resistance improver comprising a fluorine-containing resin to a non-fluorinated thermoplastic resin,wherein the light-resistance improver forms a dispersed phase having an average particle diameter of 0.01 to 2 ?m and an average interparticle distance of the dispersed phase is not more than 5 ?m,
wherein the non-fluorinated thermoplastic resin comprises at least one member selected from the group consisting of an aromatic polyamide, a liquid crystal polyester, and an aromatic polyetherketone resin,
wherein the fluorine-containing resin comprises a tetrafluoroethylene copolymer and does not include a polytetrafluoroethylene, and
the ratio of the fluorine-containing resin relative to 100 parts by weight of the non-fluorinated thermoplastic resin is 10 to 20 parts by weight.
US Pat. No. 10,249,403

P(CN)3 REACTIONS WITH LITHIUM DICYNAMIDE PRODUCING METALATED CARBON PHOSPHONITRIDE EXTENDED SOLIDS

The United States of Amer...

1. A method of making a lithiated carbon phosphonitride material, the method comprising:reacting P(CN)3 with LiN(CN)2 in solution, then
drying the solution to obtain a material comprising lithiated carbon phosphonitride.
US Pat. No. 10,245,307

PREVENTION AND REDUCTION OF BLOOD LOSS

Dyax Corp., Lexington, M...

1. A method for inhibiting plasma kallikrein in a patient in need thereof comprising,administering to the patient a composition comprising a pharmaceutically acceptable carrier and a polypeptide comprising the amino acid sequence: Xaa1 Xaa2 Xaa3 Xaa4 Cys Xaa6 Xaa7Xaa8 Xaa9 Xaa10 Xaa11 Gly Xaa13 Cys Xaa15 Xaa16 Xaa17 Xaa18 Xaa19 Xaa20 Xaa21 Xaa22Xaa23 Xaa24 Xaa25 Xaa26 Xaa27 Xaa28 Xaa29 Cys Xaa31 Xaa32 Phe Xaa34 Xaa35 Gly Gly Cys Xaa39 Xaa40 Xaa41 Xaa42 Xaa43 Xaa44 Xaa45 Xaa46 Xaa47 Xaa48 Xaa49 Xaa50 Cys Xaa52Xaa53 Xaa54 Cys Xaa56 Xaa57 Xaa58 (SEQ ID NO:1), wherein
Xaa1, Xaa2, Xaa3, Xaa4, Xaa56, Xaa57 or Xaa58 are each individually an amino acid or absent;
Xaa6, Xaa7, Xaa8, Xaa9, Xaa20, Xaa24, Xaa25, Xaa26, Xaa27, Xaa28, Xaa29, Xaa41, Xaa42, Xaa44, Xaa46, Xaa47, Xaa48, Xaa49, Xaa50, Xaa52, Xaa53, and Xaa54 are each any amino acid;
Xaa10 is Asp;
Xaa11 is an amino acid selected from the group consisting of: Asp, Gly, Ser, Val, Asn, Ile, Ala and Thr;
Xaa13 is an amino acid selected from the group consisting of: Arg, His, Pro, Asn, Ser, Thr, Ala, Gly, Lys and Gln;
Xaa15 is an amino acid selected from the group consisting of: Arg, Lys, Ala, Ser, Gly, Met, Asn and Gln;
Xaa16 is an amino acid selected from the group consisting of: Ala, Gly, Ser, Asp and Asn;
Xaa17 is an amino acid selected from the group consisting of: Ala, Asn, Ser, Ile, Gly, Val, Gln and Thr;
Xaa18 is an amino acid selected from the group consisting of: His, Leu, Gln and Ala;
Xaa19 is an amino acid selected from the group consisting of: Pro, Gln, Leu, Asn and Ile;
Xaa21 is an amino acid selected from the group consisting of: Trp, Phe, Tyr, His and Ile;
Xaa22 is an amino acid selected from the group consisting of: Tyr and Phe;
Xaa23 is an amino acid selected from the group consisting of: Tyr and Phe;
Xaa31 is an amino acid selected from the group consisting of: Glu, Asp, Gln, Asn, Ser, Ala, Val, Leu, Ile and Thr;
Xaa32 is an amino acid selected from the group consisting of: Glu, Gln, Asp Asn, Pro, Thr, Leu, Ser, Ala, Gly and Val;
Xaa34 is an amino acid selected from the group consisting of: Ile, Asn, and Leu;
Xaa35 is an amino acid selected from the group consisting of: Tyr, Trp and Phe;
Xaa39 is an amino acid selected from the group consisting of: Glu, Gly, Ala, Ser and Asp;
Xaa40 is an amino acid selected from the group consisting of: Gly and Ala;
Xaa43 is an amino acid selected from the group consisting of: Asn and Gly;
Xaa45 is an amino acid selected from the group consisting of: Phe and Tyr;
and wherein the polypeptide inhibits kallikrein.
US Pat. No. 10,246,587

TRANSPARENT POLYAMIDE-BASED COMPOSITION COMPRISING GLASS AS FILLER

ARKEMA FRANCE, Colombes ...

1. A polyamide-based transparent composition comprising:from 5.0 to 30.0% by weight of semicrystalline polyamide, wherein the semicrystalline polyamide is chosen from: PA 4.10, PA 6, PA 6.6, PA 4.6, PA 6.10, PA 6.12, PA 11, PA 12, PA 9.10, PA 9.12, PA 9.13, PA 9.14, PA 9.15, PA 9.16, PA 9.18, PA 9.36, PA 10.10, PA 10.12, PA 10.13, PA 10.14, PA 12.10, PA 12.12, PA 12.13, PA 12.14, PA 6.14, PA 6.13, PA 6.15, PA 6.16, PA 6.18, and mixtures thereof;
from 20.0 to 80.0% by weight of at least one amorphous, transparent and at least partially cycloaliphatic polyamide;
from 5.0 to 40.0% by weight of glass filler;
and optionally:
from 0.0 to 5.0% by weight of at least one copolymer comprising polyether blocks and polyamide blocks;
from 0.0 to 5.0% by weight of additives,
with respect to the total weight of the composition,
wherein the polyamide composition has a transmittance of 85% or more and a haze of less than 15% when the composition is molded into a sheet having a thickness of 2 mm.
US Pat. No. 10,245,308

COMBINATION THERAPY UTILIZING P2X7 PEPTIDES

BIOSCEPTRE (AUST) PTY LTD...

1. A method for minimising the progression of cancer in an individual who has received a non-self antibody or antigen-binding fragment thereof for treatment of the cancer, the method including the step of:forming an immune response to a P2X7 receptor in an individual who has received a non self antibody or antigen binding fragment thereof for treatment of the cancer by administering to the individual a P2X7 receptor fragment; wherein the fragment of the P2X7 receptor has an amino acid sequence selected from the group consisting of SEQ ID NO: 3 (KYYKENNVEKRTLIKVF), SEQ ID NO: 4 (GHNYTTRNILPGAGAKYYKENNVEK) and SEQ ID NO: 5 (GHNYTTRNILPGAGAKYYKENNVEKC);
wherein cancer in the individual has been reduced in size, mass or other physical measure by the administration of the non self antibody or antigen binding fragment thereof;
wherein the P2X7 receptor fragment is capable of inducing an antibody response in the individual,
thereby minimising the progression of cancer in the individual.
US Pat. No. 10,249,405

ENAMELED WIRE, SPOOL, AND METHOD OF MAKING AN ENAMELED WIRE

1. An enameled wire comprising:a metal-wire core coated with an electrically insulating enamel that contains at least one enamel polymer that is at least one polymer from the group consisting of polyamide-imide, polyester-imide, polyester-amide imide, polyimide, polyamide, polyester, and polyurethane, fluorine atoms being bonded to an outer surface of the enamel by substitution or by radical substitution as a result of a treatment of the outer surface with fluorine or fluorine gas, the outer surface or an outer layer of the enamel including enamel polymer modified with at least one siloxane or polysiloxane; and
a secondary insulation coating applied to the outer surface or to the fluorinated outer surface of the enamel.
US Pat. No. 10,245,309

ANTIGEN SPECIFIC MULTI EPITOPE-BASED ANTI-INFECTIVE VACCINES

Lior Carmon, Tel Aviv (I...

1. A method of treating a pathogenic infection in a subject in need thereof, comprising administering to the subject any one of:(i) an immunogenic composition comprising at least one peptide comprising a signal peptide domain of at least one target protein of said pathogen, wherein said peptide is not longer than 40 amino acids;
(ii) an enriched T cell population obtained by administering an immunogenic composition comprising at least one peptide comprising a signal peptide domain of at least one target protein of said pathogen to a T cell population in vitro, wherein said peptide is not longer than 40 amino acids.
US Pat. No. 10,246,589

ANTI-ICING ADDITIVE COMPOSITION FOR BITUMINOUS CONGLOMERATES

ITERCHIMICA S.R.L., Suis...

1. An ani-icing composition suitable for incorporation in bituminous conglomerates for road paving, comprising an alkali metal chloride, an alkaline-earth metal carbonate, an alkali or alkaline-earth metal formate, a polysiloxane and optionally an alkaline-earth metal chloride, in which the polysiloxane is contained in an amount between 0.5 and 2.0% by weight of the total weight of the composition.
US Pat. No. 10,247,869

LONG FILM AND METHOD FOR PRODUCING SAME

ZEON CORPORATION, Chiyod...

1. A long-length film formed of a resin containing a polymer having crystallizability, whereinthe long-length film has an orientation axis perpendicular to a long side direction of the long-length film,
the long-length film has an Nz factor Nz1 satisfying (formula 1),
the long-length film has a birefringence ?n satisfying (formula 2), and
the polymer has a crystallization degree X satisfying (formula 3):
1.0?Nz1?1.15  (formula 1)
0.01??n?0.1  (formula 2)
15%?X  (formula 3).
US Pat. No. 10,245,310

CARRIER MOLECULE FOR ANTIGENS

GlaxoSmithKline Biologica...

1. A conjugate comprising an antigen and a carrier molecule, wherein the carrier molecule comprises BP-2a polypeptides derived from different Streptococcus agalactiae strains and a Streptococcus agalactiae spb1 polypeptide as a single polypeptide chain, said polypeptide chain having an amino acid sequence at least 70% identity to SEQ ID NO:276.
US Pat. No. 10,245,311

ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN

GlaxoSmithKline Biologica...

1. A method for raising an immune response in a human comprising administering to the human a buffered immunogenic composition comprising at least two different meningococcal fHBP antigens, both of which are at least 85% adsorbed to aluminium hydroxyphosphate adjuvant.
US Pat. No. 10,249,921

FAST THERMAL DUMPING FOR BATTERIES

Elwha LLC

1. A cooling system for cooling thermal runaway in a battery, the system comprising:a fluid delivery system configured to transport a working liquid into thermal contact with the battery and further configured to permit the working liquid to vaporize upon said thermal contact to form an exhaust gas; and
an exhaust system configured to vent the exhaust gas from the fluid delivery system to the environment.
US Pat. No. 10,245,312

INFLUENZA VIRUS REASSORTMENT

Seqirus UK Limited, Berk...

1. A non-naturally occurring reassortant influenza A virus comprising six backbone viral segments, a hemagglutinin (HA) segment and a neuraminidase (NA) segment, wherein the virus comprises backbone segments from two or more donor strains, each donor strain providing more than one backbone segment, further wherein at least one backbone viral segment comprises a nucleotide sequence (a) having at least 95% identity to a sequence selected from the group consisting of SEQ ID NOs: 9-14 or SEQ ID NOs: 17-22, or (b) that encodes a viral polypeptide having at least 99% sequence identity with an amino acid sequence of a polypeptide encoded by the groups consisting of SEQ ID NOs 9-14 or SEQ ID NOs: 17-22;wherein the reassortant influenza A virus comprises PB1 and PB2 viral segments from the same donor strain and (1) the PB1 viral segment comprises a nucleotide sequence that encodes a viral polypeptide comprising the amino acid sequence of a polypeptide encoded by SEQ ID NO: 18 and (2) the PB2 viral segment comprises a nucleotide sequence that encodes a viral polypeptide comprising the amino acid sequence of a polypeptide encoded by SEQ ID NO: 19.
US Pat. No. 10,246,336

METHOD OF MAKING ALKALI ACTIVATED CARBON

CORNING INCORPORATED, Co...

1. A method of making activated carbon comprising:compressing a mixture of carbonaceous source material and an alkali source material in a press at a pressure ranging from 1,000 to 50,000 psi to produce a first solid form, wherein the mixture does not comprise a binder; and
activating the first solid form to make a second solid form comprising an activated carbon, wherein the method does not comprise a dehydration step.
US Pat. No. 10,245,313

DNA MOTIF COMPOUNDS AND METHODS FOR INDUCING SPECIFIC ANTIBODIES AND CELLULAR IMMUNITY

VERSITECH LIMITED, Hong ...

1. An immunogenic composition comprising:a mixture of different plasmids, each of which encodes a motif peptide comprising the sequence xxxxxNCSFNITTxxxx (SEQ ID NO: 1), wherein x stands for any amino acid residue, and wherein the x residues flanking NCSFNITT motif are different when compared to another plasmid in the mixture.
US Pat. No. 10,246,337

SAFE AND LOW TEMPERATURE THERMITE REACTION SYSTEMS AND METHOD TO FORM POROUS SILICON

Battelle Memorial Institu...

1. A method for preparing porous silicon, comprising:forming a mixture comprising (i) porous silica, (ii) a metal comprising aluminum, magnesium, or a combination thereof, and (iii) a metal halide comprising a metal M, where the metal M is Ti, Zn, Ga, Ge, Aq, Sn, Sb, Au, Hq, Tl, Bi, or a combination thereof, and the metal halide has a melting point ?400° C.;
heating the mixture in a sealed vessel at a temperature greater than or equal to the melting point of the metal halide and ?400° C. under an inert atmosphere to form a product comprising porous silicon; and
combining the product with acid to remove any by-products from the porous silicon.
US Pat. No. 10,246,593

SOL-GEL COATING COMPOSITIONS INCLUDING CORROSION INHIBITOR-ENCAPSULATED LAYERED DOUBLE HYDROXIDE AND RELATED PROCESSES

The Boeing Company, Chic...

1. A method comprising:adding a Zn—Al layered double hydroxide (LDH) composition to a first solution comprising a first corrosion inhibiting compound and stirring;
collecting a precipitate of the first solution; and
washing and drying the precipitate of the first solution to form a first corrosion inhibiting material (CIM), the first CIM comprising the first corrosion inhibiting compound intercalated in the Zn—Al LDH composition.
US Pat. No. 10,245,314

NON-SPECIFIC DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO TREAT HERPES SIMPLEX VIRUS INFECTION

Squarex, LLC, Pine Sprin...

1. A method of treating herpes simplex virus (HSV) infection comprising:an administering step comprising:
applying a topical immunosensitizer to the skin of a person infected with HSV at a time when the person is not having an HSV outbreak, or applying a topical immunosensitizer to the skin of a person infected with HSV during an HSV outbreak wherein the applying is at a site other than a site of an HSV lesion;
wherein the method does not further comprise (i) applying a topical immunosensitizer to the skin of a person infected with HSV on an HSV lesion at a time of an HSV outbreak in the person; or (ii) intradermally injecting a recall antigen into a person infected with HSV in an HSV lesion at the time of an HSV outbreak in the person;
wherein the method reduces the frequency of HSV outbreaks in the person after the administering step;
wherein the person has had HSV outbreaks before the administering step and is in recognized need of treatment for HSV infection;
wherein the administering step comprises applying the topical immunosensitizer to skin on the forearm or on the inner aspect of the upper arm of the person;
wherein the topical immunosensitizer comprises squaric acid dibutyl ester (SADBE); and
wherein the person has herpes labialis.
US Pat. No. 10,246,338

PROCESS FOR PREPARING PRECIPITATED SILICA USING A MIXER OR EXTRUDER

Rhodia Operations, Paris...

1. A process for preparing a precipitated silica, the process comprising:reacting a silicate with an acidifying agent to obtain a suspension of precipitated silica (S1), followed by separation to obtain a cake having a dry matter content of at least 25% by weight,
compacting the cake at a pressure higher than 10 bars and lower than 60 bars;
disintegrating the cake to obtain a suspension of precipitated silica (S2) by mixing in a twin-screw mixer or by extrusion, and
drying the suspension of precipitated silica (S2).
US Pat. No. 10,246,594

CORROSION INHIBITOR-INCORPORATED LAYERED DOUBLE HYDROXIDE AND SOL-GEL COATING COMPOSITIONS AND RELATED PROCESSES

The Boeing Company, Chic...

1. A method for providing a corrosion-resistant coating on a substrate, the method comprising:preparing a zinc-corrosion inhibitor solution by dissolving a zinc salt and a corrosion inhibitor, the corrosion inhibitor comprising a salt of an oxyanion of a transition metal; and
contacting the substrate comprising an aluminum alloy with the zinc-corrosion inhibitor solution to form a corrosion inhibitor-incorporated Zn—Al layered double hydroxide (LDH) layer on the substrate, wherein the aluminum alloy comprises 2024 aluminum alloy, 6061 aluminum alloy, or 7075 aluminum alloy.
US Pat. No. 10,245,315

MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES

CEVA SANTE ANIMALE, Libo...

1. A recombinant avian herpes virus which comprises (i) a recombinant nucleotide sequence encoding a F protein of Newcastle Disease Virus or an immunogenic fragment thereof, under the control of a Pec promoter, inserted into a non-coding region of the viral genome located between UL45 and UL46; and (ii) a recombinant nucleotide sequence encoding a VP2 protein of Infectious Bursal Disease Virus or an immunogenic fragment thereof, under the control of a mCMV IE1 promoter, inserted into a non-coding region of the viral genome located between UL44 and UL45.
US Pat. No. 10,246,339

CRYSTALLINE MOLECULAR SIEVES AND SYNTHESIS THEREOF

Chevron U.S.A. Inc., San...

1. A crystalline molecular sieve, wherein the molecular sieve has a framework of SSZ-47 and the three-dimensional framework comprising oxides of silicon and aluminum, comprising within its pore structure N,N-dimethyl-di-sec-butylammonium cation.
US Pat. No. 10,245,316

HYPO-ALLERGENIC CROSS-LINKED PROTEINS FOR USE IN THE PREVENTION OF AN ALLERGY AGAINST MILK-PROTEINS AND FOR USE IN THE INDUCTION OF ORAL TOLERANCE

FRIESLAND BRANDS B.V., A...

1. A method of reducing the risk of developing an allergy against milk proteins in a human subject predisposed to develop a milk protein allergy by inducing oral tolerance against milk proteins, comprising orally administering to the human subject a composition comprising, by weight of dry matter:(a) 10 to 15% protein, of which at least 20% is a hypo-allergenic cross-linked protein selected from cross-linked casein, cross-linked caseinate and combinations thereof:
(b) 50 to 65% carbohydrates;
(c) 22 to 30% fat and optionally
(d) 1-6% oligosaccharides.
US Pat. No. 10,246,596

WATER-BASED WHITE PIGMENT INK FOR INK-JET RECORDING

BROTHER KOGYO KABUSHIKI K...

1. A water-based white pigment ink for ink-jet recording, comprising:a white pigment; and
water, wherein
the water-based white pigment ink further comprises:
a first resin emulsion having a tensile elongation from 600% to 1200% as a film, measured in accordance with JIS K 7127; and
a second resin emulsion having a maximum tensile stress from 50 MPa to 80 MPa as a film, measured in accordance with JIS K 7127, and
a solid content (R1) of the first resin emulsion to be added and a solid content (R2) of the second resin emulsion to be added in the total amount of the ink satisfy R1/R2=0.4 to 2.5.
US Pat. No. 10,245,317

IMMUNOGENIC COMPOSITION

GLAXOSMITHKLINE BIOLOGICA...

1. An immunogenic composition, comprising:(a) a Neisseria meningitidis (N. meningitides) serogroup A capsular saccharide conjugated to an adipic acid dihydrazide (ADH) linker, wherein the linker is conjugated to tetanus toxoid carrier protein;
(b) a N. meningitidis serogroup C capsular saccharide conjugated to an adipic acid dihydrazide (ADH) linker, wherein the linker is conjugated to tetanus toxoid carrier protein;
(c) a N. meningitidis serogroup W capsular saccharide directly conjugated to tetanus toxoid carrier protein in the absence of a linker; and
(d) a N. meningitidis serogroup Y capsular saccharide directly conjugated to tetanus toxoid carrier protein in the absence of a linker;
wherein the ratio of Men A saccharide to carrier protein is between 1:2 to 1:5 (w/w); and wherein the ratio of MenC saccharide to carrier protein is between 1:2 to 1:5 (w/w).
US Pat. No. 10,246,597

OIL-BASED RECORDING LIQUID

Seiko Epson Corporation, ...

1. An oil-based recording liquid, comprising:a color material; and
an oil-based medium,
wherein the oil-based medium contains a first organic medium having an SP value of 9.5 or more and an iodine value of 120 or more,
the content of the first organic medium is 50 percent by mass or more, and
the content of a second organic medium having an SP value of 9.0 or less and an iodine value of 100 or less, in the oil-based recording liquid is 30 percent by mass or less.
US Pat. No. 10,245,318

FLAGELLIN-CONTAINING PROTEIN NANOPARTICLES AS A VACCINE PLATFORM

ALPHA-O PEPTIDES AG, Rie...

1. A self-assembling protein nanoparticle consisting of aggregates of a multitude of building blocks of formula (Ia) or (Ib)X-ND1-L1-ND2-FLA  (Ia)
or
FLA-ND1-L1-ND2-X  (Ib),
consisting of a continuous chain comprising a protein oligomerization domain ND1, a linker L1, a protein oligomerization domain ND2, FLA, and a further substituent X, wherein
ND1 is a protein that forms oligomers (ND1)m of m subunits ND1,
ND2 is a protein that forms oligomers (ND2)n of n subunits ND2,
m and n each is a figure between 2 and 10, with the proviso that m is not equal to n and not a multiple of n, and n is not a multiple of m,
L1 is a bond or a short flexible linker,
FLA is flagellin, or a derivative of flagellin lacking parts of the flagellin amino acid sequence but at least containing the TLR5 binding domain D1, and wherein the lacking parts are (a) replaced by a flexible linker segment of 1 to 20 amino acids joining two ends of the flagellin amino acid sequence or (b) are replaced by a fully folded protein antigen;
X is absent or a peptide or protein sequence comprising 1 to 1000 amino acids,
optionally co-assembled with a multitude of building blocks of the formula (II)
Y-ND3-L2-ND4-Z  (II),
consisting of a continuous chain comprising a protein oligomerization domain ND3, a linker L2, a protein oligomerization domain ND4, and further substituents Y and Z, wherein
ND3 is a protein that forms oligomers (ND3)y of y subunits ND3,
ND4 is a protein that forms oligomers (ND4)z of z subunits ND4,
y and z each is a figure between 2 and 10, with the proviso that y is not equal to z and not a multiple of z, and z is not a multiple of y, and wherein
either ND3 is identical to ND1, or ND4 is identical to ND2 or both ND3 and ND4 are identical to ND1 and ND2, respectively,
L2 is a bond or a short flexible linker that may be different from L1 or identical to L1, and
Y and Z are, independently of each other, absent or a peptide or protein sequence comprising 1 to 1000 amino acids.
US Pat. No. 10,245,319

LYMPH NODE-TARGETING NANOPARTICLES

Duke University, Durham,...

1. A method of treating asthma comprising administering to a subject a nanoparticle comprising:heparin; and
chitosan,
wherein the heparin and the chitosan nanoparticle encapsulates IL-12, and
wherein the nanoparticle is administered by a route selected from the group consisting of oral, sublingual, intramuscular, subcutaneous, intravenous, transdermal, topical, parenteral, buccal, rectal, mucosal, intranasal, injection, inhalation, implant, and a combination thereof.
US Pat. No. 10,246,343

PROCESSING OF COBALTOUS SULPHA/DITHIONATE LIQUORS DERIVED FROM COBALT RESOURCE

Rocher Manganese, Inc., ...

1. A process of water removal and/or recycling from sodium sulphate and sodium dithionate containing liquor derived from processing cobalt resource material essentially free of lithium, comprising the steps of:a. precipitation of cobalt as cobaltous carbonate in whole or in part followed by its removal in whole or in part from the liquor by centrifugation or filtration;
b. crystallization of sodium sulphate and sodium dithionate to separate the majority of sodium sulphate and sodium dithionate from the liquor;
c. heating of the sodium sulphate and sodium dithionate crystals to form anhydrous sodium sulphate, sulphur dioxide and water; and
d. separation of anhydrous sodium sulphate from the sulfur dioxide and water.
US Pat. No. 10,245,320

IMMUNOMODULATORY PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

Enzo Biochem, Inc., New ...

1. An immunomodulatory pharmaceutical composition comprising:(a) at least substantially pure alpha-synuclein protein; and
(b) at least one preselected antigen or immunogen, which is not a human or non-human mammalian alpha-synuclein protein or a fragment thereof.
US Pat. No. 10,245,321

COMBINATION THERAPY FOR INDUCING IMMUNE RESPONSE TO DISEASE

IBC Pharmaceuticals, Inc....

1. A composition comprising bispecific antibody that comprisesa) a first antibody moiety that binds to human CD3, conjugated to an AD (anchoring domain) moiety from an AKAP protein; and
b) a second antibody moiety that binds to human Trop-2, conjugated to a DDD (dimerization and docking domain) moiety, wherein the amino acid sequence of said DDD moiety is residues 1-44 of human protein kinase A (PKA) RII?;wherein two copies of the DDD moiety form a dimer that binds to one copy of the AD moiety to form the bispecific antibody.
US Pat. No. 10,245,578

CHROMIUM- AND NICKEL-FREE HYDROGENATION OF HYDROFORMYLATION MIXTURES

EVONIK DEGUSSA GMBH, Ess...

1. A process for preparing alcohols by hydrogenation of aldehydes, in which a feed mixture comprises the step ofa) contacting an aldehyde and an accompanying component is contacted with a heterogeneous catalyst in the presence of hydrogen, giving a product mixture comprising the alcohol corresponding to the hydrogenated aldehyde, and a by-product,
wherein the heterogeneous catalyst comprises a support material and copper applied thereto,
wherein the support material is silicon dioxide;
and the catalyst in activated form has the following composition that adds up to 100% by weight:
silicon dioxide: from 86% by weight to 90% by weight;
copper: from 10% by weight to 14% by weight;
nickel: from 0 ppm by weight to 50 ppm by weight;
chromium: from 0 ppm by weight to 50 ppm by weight;
aluminium oxide: from 0 ppm by weight to 1000 ppm by weight;
other substances: from 0 ppm by weight to 1% by weight
wherein the support material makes up from 86% to 90% by of the composition and the remaining components set forth above make up from 10% to 14% by weight of the composition and wherein the yield of the alcohol is from 95% to 99%.
US Pat. No. 10,246,602

POLYOLEFIN COMPOUNDS FOR CABLE COATINGS

1. A coated conductor comprising:(a) a conductor; and
(b) a polymeric composition surrounding at least a portion of said conductor,
wherein said polymeric composition comprises a high-density polyethylene and an ethylene vinyl acetate,
wherein said polymeric composition has a vinyl acetate content in the range of from 1.5 to 8 weight percent, based on the combined weight of said high-density polyethylene and said ethylene vinyl acetate,
wherein said polymeric composition has a melt index (I2) in the range of from 1.3 to 1.9 g/10 min.,
wherein said ethylene vinyl acetate has a vinyl acetate content in the range of from 18 to 28 weight percent, based on the total weight of said ethylene vinyl acetate.
US Pat. No. 10,245,324

OPHTHALMIC COMPOSITION

21. A method of reducing the precipitation of a polyquaternium compound and an anionic polymer in an eye composition comprising such compounds, comprising the steps of:i) providing from about 0.001% to about 0.5% of an anionic polymer having a weight average molecular weight of from about 250 to about 4,000,000 Daltons;
ii) adding an effective amount of an organic acid, salts thereof or mixtures thereof, to achieve complete association of the organic acid with the polyquaternium compound such that the organic acid binds with the polyquaternium compound at at least a 1:1 molar ratio; and
iii) adding from about 10 ppm to about 1000 ppm of a polyquaternium compound having a weight average molecular weight of from about 150 to about 15,000 Daltons;
wherein the composition is substantially free of cationic oligomer compounds and precipitation inhibiting compounds and wherein the composition is in the form of an eye-drop solution, an eye wash solution, or a solution, spray or mist for lubricating or rewetting a contact lens.
US Pat. No. 10,245,581

COMPOSITION AND PROCESS FOR PREPARATION OF ATTRITION RESISTANT ADDITIVE SUITABLE FOR CRACKING HYDROCARBON FEED

INDIAN OIL CORPORATION LI...

1. An attrition resistant hydrocarbon cracking catalyst additive composition comprising an aluminium phosphate binder, wherein said aluminium phosphate binder has zeta potential in the range of ?40 mv to ?60 mv in liquid form and a surface area in the range of 80-200 m2/gm in dry form;wherein said additive composition comprises:
a) 10-70 wt % ZSM-5 zeolite;
b) 5-12 wt % of the aluminium phosphate binder;
c) 5-20 wt % colloidal silica;
d) 10-60 wt % clay; and
e) 1-12 wt % phosphate.
US Pat. No. 10,245,582

ZEOLITE CATALYST CONTAINING METALS

Johnson Matthey Public Li...

1. A catalyst composition comprising:a. an aluminosilicate zeolite material comprising silica and alumina in a CHA framework and having a silica-to-alumina mole ratio (SAR) of about 10 to about 25;
b. about 1 to about 5 weight percent of a base metal (“BM”), based on the total weight of the zeolite material, wherein said base metal disposed in said zeolite material as free and/or extra-framework exchanged metal;
c. an alkali or alkaline earth metal (collectively “AM”) disposed in said zeolite material disposed in said zeolite material as free and/or extra-framework exchanged metal,
wherein the BM and AM are present, respectively, in a molar ratio of about 15:1 to about 1:1,
wherein the alumina contains aluminum (Al) that is part of the zeolite framework and the catalyst composition has a (BM+AM):Al mole ratio of about 0.1 to about 0.4, and
wherein AM is calcium; and
d. about 1 to about 10 weight percent of cerium in said zeolite material, based on the total weight of the zeolite, wherein said cerium is present in a form selected from exchanged cerium ions, monomeric ceria, oligomeric ceria, and combinations thereof, provided that said oligomeric ceria has a particle size of less than 5 ?m.
US Pat. No. 10,246,606

TRANSPARENT FLEXIBLE HARD COATED FILM AND METHOD OF PRODUCING THE SAME

KOREA ADVANCED INSTITUTE ...

1. An ionic polymerizable siloxane hard coating composition for forming a transparent flexible hard coated film, the composition comprising:oligosiloxane [component (A)] having on average at least one alicyclic epoxy group per molecule;
a reactive diluent [component (B)] that is (3,4-epoxycyclohexyl)methyl 3,4-epoxycyclohexylcarboxylate or that has on average at least one oxetane group per molecule; and
an ionic polymerization initiator [component (C)],
wherein the ionic polymerizable siloxane hard coating composition is produced by a method including mixing the component (C) of from 0.1 part by weight to 10 parts by weight with respect to 100 parts by weight of the component (A),
wherein the component (A) has an average unit chemical formula represented by the following Chemical Formula 1:
(R1SiO3/2)a(R22SiO2/2)b(R33SiO1/2)c(SiO4/2)d(R4O1/2)e,  [Chemical Formula 1]
wherein in Chemical Formula 1,
R1 is an alicyclic epoxy group, and R2 and R3 are each independently selected from the group consisting of a substitutable C1-20 alkyl group, a substitutable C2-20 alkenyl group, a substitutable C2-20 alkynyl group, and a substitutable C6-20 aryl group, a substitutable substituent in the R2, and R3 is at least one member selected from the group consisting of a C1-20 alkyl group, a C3-8 cycloalkyl group, a C1-20 alkoxy group, an amino group, an acryl group, a (meth)acryl group, halogen, an allyl group, a mercapto group, an ether group, an ester group, a carbonyl group, a carboxyl group, a vinyl group, a nitro group, a sulfone group, a hydroxyl group, a cyclobutene group, an alkyd group, an urethane group, an oxetane group, a phenyl group, and combinations thereof,
R4 is a straight or branched C1-7 alkyl group or hydrogen,
a is a positive number,
b is 0 or a positive number,
c is 0 or a positive number,
d is 0 or a positive number,
e is 0 or a positive number,
(b+c+d)/a is a number of from 0 to 1,
e/(a+b+c+d) is a number of from 0 to 0.4, and
the alicyclic epoxy group is not a glycidyl group.
US Pat. No. 10,245,327

CELL PENETRATING PEPTIDE, CONJUGATE COMPRISING SAME, AND COMPOSITION COMPRISING CONJUGATE

1. A conjugate having cell penetrating activity, wherein the conjugate comprises a cell penetrating carrier peptide and an active ingredient, the carrier peptide is 11 amino acids in length and consists of the amino acid sequence of SEQ ID NO:139, and wherein the carrier peptide increases the cell penetration of the active ingredient.
US Pat. No. 10,246,607

RESIN COMPOSITION, COATING COMPOSITION AND ARTICLE BY USING THE SAME

CHANG CHUN PLASTICS CO., ...

1. A resin composition comprising:a component (i): an epoxy resin comprising an epoxidized tricyclo decanedimethanol, and
a component (ii): an epoxy resin comprising an epoxidized cardanol.
US Pat. No. 10,246,608

NON-FLUORINATED URETHANE BASED COATINGS

THE CHEMOURS COMPANY FC, ...

1. An aqueous composition comprising at least one hydrophobic compound having at least one linkage of Formula I:—NHC(O)—X—  (I)
wherein
the linkage of Formula (I) composes 30 to 100% by mol of the total urethane linkages in the hydrophobic compound;
X is the residue of a cyclic or acyclic sugar alcohol which is substituted with at least two —R1; —C(O)R1; —(CH2CH2O)n(CH(CH3)CH2O)mC(O)R1; or mixtures thereof;
where the cyclic or acyclic sugar alcohol is selected from a saccharide, reduced sugar, aminosaccharide, aldonic acid, or aldonic acid lactone; wherein
each n is independently 0 to 20;
each m is independently 0 to 20;
m+n is greater than 0; and
each R1 is independently a linear or branched alkyl group having 5 to 29 carbons.
US Pat. No. 10,246,609

PIGMENTED COATING MATERIAL AND PROCESS FOR PRODUCING A MULTI-COAT PAINT SYSTEM USING THE PIGMENTED COATING MATERIAL

BASF Coatings GmbH, Muen...

1. A solvent-based pigmented coating composition comprising(A) at least one binder comprising at least one acrylate polymer, polyurethane polymer, or polyester,
(B) at least one crosslinking agent selected from the group of blocked polyisocyanates and amino resins,
(C) at least one pigment, and
(D) at least one organic solvent that is n-pentyl acetate, n-pentyl glycol, or n-hexyl glycol,
wherein the solids content of the coating composition is at least 35% by weight.
US Pat. No. 10,246,610

COATING COMPOSITION

PPG Industries Ohio, Inc....

1. A coating composition comprising a resin material comprising a polyester imide polymer; one or more titanate material; one or more OH reactive cross linking material and one or more acidic polyester material.
US Pat. No. 10,245,331

CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT

The General Hospital Corp...

1. A method for treating Alzheimer's disease in a subject in need thereof consisting of co-administering:by inhalation cromolyn sodium in the form of a dry powder, and
by mouth from 1 mg to 25 mg of ibuprofen per day,wherein the dry powder is micronized and further comprises an excipient.
US Pat. No. 10,246,612

ADHESIVE TAPE

LG Chem, Ltd., (KR)

1. An adhesive tape for use in bonding of a TV bezel, sequentially comprising:a first adhesive layer;
an inner polyurethane foamed layer, having a density of 0.1 g/cm3 to 0.5 g/cm3; and
a second adhesive layer,
wherein the polyurethane foamed layer has pores with an average diameter of 50 microns to 200 microns,
wherein the polyurethane foamed layer has a thickness of 0.2 mm to less than 5.0 mm; and
wherein the adhesive tape has a width of 1 mm to 7 mm,
wherein the polyurethane foamed layer has a compressive strength of 100 gf/in2 to 2000 gf/in2,
wherein the polyurethane foamed layer has a tensile strength of 2 kgf/in2 to 20 kgf/in2, and
wherein the adhesive layers comprise at least one of acrylic adhesives, rubber adhesives, silicone adhesives, or combinations thereof.
US Pat. No. 10,245,590

HIGH-SPEED REAL-TIME PCR DEVICE BASED ON LAB-ON-A-CHIP FOR DETECTING FOOD-BORNE BACTERIA TO AGRIFOOD, AND METHODS FOR DETECTING FOOD-BORNE BACTERIA TO AGRIFOOD USING THE SAME

NANOBIOSYS INC., Seoul (...

1. A micro Polymerase Chain Reaction (PCR) chip, comprising: a reaction chamber having an opened upper surface intended to receive a fluid; and a cover intended to seal the reaction chamber, the cover comprising a light-transmitting portion of a light transmitting material which is faced with the opened upper surface of the PCR reaction chamber to close the open upper surface, the light-transmitting portion having a protruding part that extends toward the interior of the reaction chamber from regions of closed surfaces faced on the opened upper surface of the chamber, and the end of the protruding part being adjacent to or in contact with the surface of said fluid, wherein the protruding part of the light-transmitting portion is located in an optical path between a light-emitting module and a light-detecting module for detecting optical signals in said fluid.
US Pat. No. 10,246,614

STARCH-BASED GLUE COMPOSITION

ARGANA STAERKE GMBH, Gmu...

1. A method of preparing a layered or laminated product, which comprises the steps of:providing a glue composition having an enzymatically branched starch with a viscosity stability index SI of less than or equal to 1.3, calculated by a quotient from viscosity after 14 days and the viscosity after 2 hours after preparation of the glue composition, wherein said starch has a mean molecular weight Mw (weight average), measured by light scattering, of from 60 kDa to 3000 kDa; and
applying the glue composition as a gluing agent or a laminating agent to two surfaces of at least one of paper products, cardboard products, and displays made from paper or cardboard, wherein the glue composition bonds the two surfaces together to form a layered or laminated product.
US Pat. No. 10,245,847

REACTION SOLUTION AND INK JET RECORDING METHOD

Seiko Epson Corporation, ...

1. A reaction solution comprising:any one or more kinds of organic solvents from esters, alkylene glycol ethers, cyclic esters, and alkoxyalkyl amides; and
an aggregating agent which aggregates components of an ink composition,
wherein the reaction solution is used for a recording method performed by using the ink composition; and
the one or more kinds of organic solvents includes an organic solvent of which a degree of solubility is equal to or greater than 1% by mass with respect to an aqueous solution having a concentration of 2-pyrrolidone of 20% by mass.
US Pat. No. 10,246,617

ADHESIVES WITH LOW VOC AND FOGGING VALUES

EVONIK DEGUSSA GMBH, Ess...

1. A hotmelt adhesive comprising polyesters based on polycarboxylic acids and di- or polyols, comprising dicarboxylic acids of the formula HOOC—(CH2)x-COOH with x>10 and diols of the formula HO—(CH2)y-OH, with the proviso that at least 50 mole percent of the dicarboxylic acids, based on the total amount of polycarboxylic acid components, and at least 50 mole percent of the diols, based on the total amount of di- or polyols, satisfy the condition x+y?18.
US Pat. No. 10,246,618

PEBA FOR DIRECT ADHESION TO TPE

Arkema France, Colombes ...

1. A composite article comprising at least two polymer materials which adhere directly to one another, wherein:a first polymer material is made of a copolymer having polyamide PA blocks and polyether PE blocks (PEBA), in which the number of carbons of the diamine in the PA blocks is within the range from 6 to 14, and the number of carbons of the diacid in the PA blocks is within the range from 6 to 18, and
a second polymer material is made of thermoplastic elastomer (TPE) chosen from identical PEBA with a flexural modulus different from that of the copolymer, PEBA of composition different from that of the said copolymer, copolyether-block-ester (COPE) and/or copolyether-block-urethane (TPU).
US Pat. No. 10,246,622

COOLANT HAVING RAPID METAL PASSIVATION PROPERTIES

Arteco NV, Schoten (BE)

1. A heat transfer solution which provides passivation when placed in contact with metal surfaces, said solution comprising:(a) water, an alcohol, or a mixture of both;
(b) from 0.01 to 1 wt % of a nitrite;
(c) from 0.0001 to 1 wt % of a phosphonate or a phosphinate,
the phosphonate having the formula R—[CR2]m—PO3M2 wherein each R-group is selected from the group consisting of hydrogen, alkyl, alkenyl, hydroxyl, phosphono group, carbonyl group, amino, alkylamino and an aryl group, wherein m is 1 or an integer greater than 1, and each M is hydrogen or an alkali metal ion;
the phosphinate having the formula R—[CR2]m—P(O2M)H wherein each R-group is selected from the group consisting of hydrogen, alkyl, alkenyl, hydroxyl, phosphino group, carbonyl group, amino, alkylamino and an aryl group, wherein m is 1 or an integer greater than 1, and M is hydrogen or an alkali metal ion;
(d) an alkaline earth metal compound; and
(e) a corrosion inhibitor selected from the group consisting of 2-ethylhexanoic acid, sebacic acid, and mixtures thereof,
wherein the heat transfer solution is free of inorganic phosphates.
US Pat. No. 10,246,368

OPTICAL GLASS, OPTICAL ELEMENT AND OPTICAL DEVICE USING OPTICAL GLASS

NIKON CORPORATION, Tokyo...

1. An optical glass containing respective components ofSiO2 from 14 to 26% by mass,
B2O3 from 9 to 16% by mass, and
La2O3 from 10 to 42% by mass
as essential components, and
containing respective components of ZnO, Y2O3, ZrO2, Ta2O5, Li2O, and Na2O as optional components, and
satisfying respective relationships of
SiO2+B2O3 from 28 to 36% by mass,
ZrO2+Ta2O5 from 6 to 16% by mass,
La2O3+Y2O3+ZnO from 43 to 59% by mass, and
Li2O+Na2O from 2 to 14% by mass.
US Pat. No. 10,249,442

METHOD FOR MANUFACTURING HIGH-VOLTAGE SOLID ELECTROLYTE ALUMINUM-ELECTROLYTIC CAPACITOR

Zhaoqing Beryl Electronic...

1. A method for manufacturing a solid electrolyte aluminum-electrolytic capacitor, comprising:(1) welding a capacitor core of a capacitor onto an iron bar, applying a voltage for chemical treatment, and after the chemical treatment, washing and drying the capacitor core;
(2) impregnating the dried capacitor core in a dispersion B for 1˜30 minutes;
(3) removing the capacitor core out of the dispersion B, creating a vacuum and then impregnating the capacitor core in the dispersion B for 1˜10 minutes;
(4) keeping the capacitor core in the dispersion B, breaking the vacuum and then performing pressurization, and keeping the pressurized state for 1˜10 minutes;
(5) keeping the capacitor core in the dispersion B, performing depressurization to an atmospheric pressure, and keeping the atmospheric pressure for 1˜10 minutes;
(6) taking the capacitor core out, placing the capacitor core in a temperature of 50˜100° C. and drying it for 20˜60 minutes, and then placing the capacitor core in a temperature of 110˜200° C. and drying it for 20˜60 minutes;
(7) impregnating the dried capacitor core in a dispersion C for 1˜30 minutes;
(8) taking the capacitor core out, placing the capacitor core in a temperature of 65˜100° C. and drying it for 20˜60 minutes, and then placing the capacitor core in a temperature of 135˜165° C. and drying it for 20˜60 minutes;
(9) Repeating steps (3) to (8) at least once;
(10) Putting the capacitor core in an aluminum cover and sealing it, and performing aging treatment to obtain a solid electrolyte aluminum-electrolytic capacitor, wherein
the dispersion B is a dispersion inclusive of both a conductive polymer and a conductive carbon material; the dispersion C is a dispersion inclusive of a conductive carbon material.
US Pat. No. 10,245,347

ELASTOMER COMPOSITION COMPRISING POLYOLEFIN ELASTOMERS

1. An elastomer composition comprising a polyolefin elastomer material, the elastomer composition having the following properties:(1) an average integrated enthalpy sum from 5 J/g to 17 J/g;
(2) an average integrated enthalpy ratio of from 0.6 to 300; and
(3) a load stress/unload stress ratio at 75% strain of 1 to 2.6.
US Pat. No. 10,246,371

ARTICLES INCLUDING GLASS AND/OR GLASS-CERAMICS AND METHODS OF MAKING THE SAME

CORNING INCORPORATED, Co...

1. An article, comprising:SiO2 from about 40 mol % to about 80 mol %;
Al2O3 from about 1 mol % to about 20 mol %;
B2O3 from about 3 mol % to about 50 mol %;
WO3 plus MoO3 from about 1 mol % to about 18 mol %, wherein WO3 is about 1.0 mol % or greater;
at least one of: (i) Au from about 0.001 mol % to about 0.5 mol %, (ii) Ag from about 0.025 mol % to about 1.5 mol %, and (iii) Cu from about 0.03 mol % to about 1 mol %;
a plurality of crystalline precipitates comprising an oxide of the chemical form MxWO3 or MxMoO3, wherein M is one or more of H, Li, Na, K, Rb, Cs, Ca, Sr, Ba, Zn, Ag, Au, Cu, Sn, Cd, In, Tl, Pb, Bi, Th, La, Pr, Nd, Sm, Eu, Gd, Dy, Ho, Er, Tm, Yb, Lu, and U, and wherein 0 R2O from about 0 mol % to about 15 mol %, wherein the R2O is one or more of Li2O, Na2O, K2O, Rb2O and Cs2O,
wherein R2O minus Al2O3 ranges from about ?12 mol % to about 3.8 mol %.
US Pat. No. 10,245,348

PROCESS FOR MAKING DRY AND STABLE HEMOSTATIC COMPOSITIONS

Baxter International Inc....

1. A process for making a dry and stable hemostatic composition, the process comprising:lyophilizing an aqueous preparation of thrombin in a container so as to provide a first component in the container, the first component comprising a dry preparation of thrombin;
compacting the first component in the container following the lyophilizing step;
adding a second component to the container following the lyophilizing step, the second component comprising a dry preparation of a biocompatible polymer suitable for use in hemostasis;
mixing the first component and the second component, so as to obtain a dry mixture of the first component with the second component in the container;
and finishing the container to a storable pharmaceutical device containing the first component and the second component in a combined form as a dry and stable hemostatic composition.
US Pat. No. 10,245,349

BIRTH TISSUE MATERIAL AND METHOD OF PREPARATION

BioDlogics, LLC, Cordova...

1. A method of treating a soft tissue defect in or on the body of a patient comprising the steps of:providing a placental construct comprising: i) a therapeutically effective amount of a human birth tissue material that is cryofrozen, morselized and subsequently suspended in a tissue suspension solution; and ii) an amniotic fluid composition; and
administering the placental construct directly into or onto the soft tissue defect,
wherein the tissue suspension solution comprises about 36% volume of human albumin 25% solution and about 20% volume of dimethyl sulfoxide.
US Pat. No. 10,246,373

CURABLE FIBERGLASS BINDER

Johns Manville, Denver, ...

1. A process of making a formaldehyde-free fiberglass product, wherein the process comprises:applying a binder composition to glass fibers, wherein the binder composition comprises:
an aldehyde or ketone, and
an amino-amide oligomer consisting of an addition product of an amine and a carbonyl-containing compound; and
curing the binder composition while present on the glass fibers to make the formaldehyde-free fiberglass product, wherein the cured binder composition includes reaction products of the aldehyde or ketone and the amino-amide oligomer.
US Pat. No. 10,245,351

MALLEABLE HYDROGEL HYBRIDS MADE OF SELF-ASSEMBLED PEPTIDES AND BIOCOMPATIBLE POLYMERS AND USES THEREOF

Technology Innovation Mom...

1. A hydrogel comprising a fibrous network of a plurality of peptides and at least one biocompatible polymer, wherein said peptides are capable of self-assembling in an aqueous solution so as to form a hydrogel, wherein each peptide in said plurality of peptides comprises an amino acid sequence not exceeding 6 amino acids in length, said amino acid sequence comprising at least one aromatic amino acid residue, and wherein said biocompatible polymer features at least one characteristic selected from the group consisting of:(i) a storage modulus G? lower than 500 Pa at 10 Hz frequency and at 25° C.;
(ii) a swelling ratio (Q) higher than 500;
(iii) a viscosity at 0.1 Sec?1 shear rate and at 25° C., lower than 300 Pa·s; and
(iv) a viscosity recovery after shear of at least 95%.
US Pat. No. 10,247,656

SINGLE-CELL MICROCHAMBER ARRAY

1. An apparatus for analyzing individual cell composition in a heterogeneous cell population, the apparatus comprising:a deposition plate having an array of microwells disposed therein;
a cover plate overlying the deposition plate and sealing the microwells of the array of microwells from one another and sealing the microwells of the array of microwells, the cover plate having a planar lower surface, each microwell of the array of microwells and a portion of the planar lower surface over the each microwell defining a sealed volume; and
a pair of electrodes associated with at least one microwell in the deposition plate and configured to generate an electric field within the at least one microwell, the pair of electrodes being formed on the portion of the planar lower surface over the at least one microwell.
US Pat. No. 10,246,633

HIGHLY STABLE QUANTUM DOT-CONTAINING POLYMER FILMS

Nanoco Technologies Ltd.,...

1. A film comprising:a plurality of semiconductor nanoparticles dispersed in a cured inner phase that comprises lauryl methacrylate and trimethylolpropane trimethacrylate; and,
an outer phase that comprises an acrylate-functionalized silica nanoparticle resin.
US Pat. No. 10,245,354

METHOD FOR MANUFACTURING HOLLOW NEEDLE-SHAPED BODY, AND HOLLOW NEEDLE-SHAPED BODY

TOPPAN PRINTING CO., LTD....

11. A method for manufacturing a hollow needle-shaped body, comprising:producing a crystallized polyglycolic acid body having a substrate portion and a projection portion formed on a first surface of the substrate portion; and
applying a laser beam to a second surface of the substrate portion opposite to the first surface such that a through hole that penetrates through the substrate portion and the projection portion is formed,
wherein the crystallized polyglycolic acid body is made of crystallized polyglycolic acid having a degree of crystallization in a range of 40% to 90%.
US Pat. No. 10,245,356

MEDICAL DEVICES WITH NON-UNIFORM COATINGS FOR ENHANCED ECHOGENICITY

ENCAPSON B.V., Enschede ...

1. A medical device comprising a coating for ultrasound detection, said coating comprising microparticles that are visible with ultrasound, wherein the microparticles are solid throughout, wherein the diameter of at least 60% of said microparticles on said medical device is between 10 and 45 ?m and the density of said microparticles per surface area is between 45 and 450 particles/mm2, and wherein said coating is applied as a pattern that spatially selectively covers parts of the surface.
US Pat. No. 10,246,380

SOLID WASTE TREATMENT METHOD

B.A.M.2 Waste Water Consu...

1. A solid waste treatment method consisting of the steps of:a. chlorinating solid waste having a first biological oxygen demand to produce degraded and sterilized solid waste and residual solid waste;
b. measuring the residual solid waste for chlorine residuals, and if residual chlorine is:
i) present, dechlorinating the residual solid waste to produce dechlorinated residual solid waste; or
ii) not present, determining that the residual solid waste is dechlorinated residual solid waste;
c. adding a flocculating composition to the dechlorinated residual solid waste to solubilize the dechlorinated residual solid waste;
d. inoculating the dechlorinated residual solid waste with bacteria, selected from the group of aerobic bacteria, facultative bacteria and combinations thereof, wherein the bacteria biodegrade the dechlorinated residual solid waste.
US Pat. No. 10,246,637

ONE-POT METHOD FOR PREPARING CORE-SHELL NANOCRYSTALS

Massachusetts Institute o...

1. A method for preparing a core-shell nanocrystal comprising:mixing an M-containing precursor solution, an X-containing precursor solution, and an acid or alcohol in an inert atmosphere at a first temperature to form a reaction mixture;
maintaining the reaction mixture at the first temperature to grow an MX semiconductor crystalline core of the nanocrystal;
raising the temperature of the reaction mixture to a second temperature; and
maintaining the reaction mixture at the second temperature to grow a semiconductor crystalline shell of the nanocrystal for a period of between 5 to 120 minutes.
US Pat. No. 10,246,383

PROCESS FOR PRODUCING PARAXYLENE BY METHYLATION OF BENZENE AND/OR TOLUENE

ExxonMobil Chemical Paten...

1. A process for producing paraxylene, the process comprising:(a) selectivating an alkylation catalyst consisting essentially of MCM-49 zeolite and alumina binder by contacting the alkylation catalyst with a selectivating agent selected from the group consisting of silicon, steam, and a combination of silicon and steam;
(b) contacting an aromatic hydrocarbon feed comprising toluene with an alkylating reagent comprising methanol and/or dimethyl ether in at least one alkylation reaction zone in the presence of the alkylation catalyst under alkylation conditions comprising a temperature less than 500° C. and a pressure of 700 kPa-a to 7000 kPa-a to produce an alkylated aromatic product comprising xylenes, wherein the at least one alkylation reaction zone comprises a fixed bed of the alkylation catalyst; and
(c) recovering paraxylene from the alkylated aromatic product.
US Pat. No. 10,246,641

PROCESSES FOR PRODUCING HYDROCARBON PRODUCTS

THE COMMONWEALTH SCIENTIF...

1. A process for producing extracted plant lipid, the process comprising the steps of:i) extracting lipid from a collection of transgenic vegetative plant parts having a total non-polar lipid content of at least 10% (w/w dry weight); and
ii) recovering the extracted lipid.
US Pat. No. 10,246,642

PROCESS TO PRODUCE BLOWN ASPHALT

SAUDI ARABIAN OIL COMPANY...

1. A process for producing blown asphalt, the process comprising the steps of:mixing a heated hydrocarbon stream and a supercritical water in a mixer to produce a mixed stream, where the heated hydrocarbon stream has a temperature less than the temperature of the critical temperature of water and a pressure between 23 MPa and 35 MPa, where the supercritical water has a temperature between the critical temperature of water and 600 deg C. and a pressure of 23 MPa to 35 MPa, where the mixed stream comprises water and hydrocarbons having an asphaltene fraction;
introducing the mixed stream to a supercritical water reactor;
operating the supercritical water reactor at a reaction temperature and a reaction pressure for a residence time to produce a reactor effluent;
introducing the reactor effluent to a cooler;
reducing the temperature of the reactor effluent in the cooler to produce a cooled effluent;
feeding the cooled effluent through a depressurizing device to produce a depressurized stream;
introducing the depressurized stream to a flash drum;
separating the depressurized stream in the flash drum to produce a light fraction stream and a heavy fraction stream, where the light fraction stream contains light hydrocarbons and water, where the heavy fraction stream contains a maltene fraction, an asphaltene fraction, and water;
introducing the heavy fraction stream to a storage tank, the storage tank configured to store the heavy fraction stream;
withdrawing an oxidizing reactor feed from the storage tank;
introducing the oxidizing reactor feed to an oxidation reactor;
introducing an oxygen source to the oxidation reactor, where the oxidation source comprises molecular oxygen; and
operating the oxidation reactor at an oxidation temperature and an oxidation pressure to produce a product effluent, where the product effluent comprises an oxidized asphaltene fraction.
US Pat. No. 10,246,387

PROCESS FOR SELECTIVATING CATALYST FOR PRODUCING PARAXYLENE BY METHYLATION OF BENZENE AND/OR TOLUENE

ExxonMobil Chemical Paten...

1. A process for producing paraxylene, the process comprising:(a) selectivating an alkylation catalyst consisting essentially of MCM-49 and alumina binder by contacting the alkylation catalyst with a selectivating agent selected from the group consisting of silicon, steam, and a combination of silicon and steam;
(b) contacting an aromatic hydrocarbon feed comprising benzene and/or toluene with an alkylating reagent comprising methanol and/or dimethyl ether in at least one alkylation reaction zone in the presence of the alkylation catalyst under alkylation conditions comprising a temperature less than 500° C. to produce an alkylated aromatic product comprising xylenes; wherein the molar ratio of the alkylating reagent to benzene and/or toluene of at least 1:4 is used at least until the amount of paraxylene as a percentage of the total xylenes produced is equal to or greater than 23 wt. %; and(b) recovering paraxylene from the alkylated aromatic product.
US Pat. No. 10,246,388

PROCESS FOR THE REDUCTION OF RFC?CX IMPURITIES IN FLUOROOLEFINS

THE CHEMOURS COMPANY FC, ...

1. A process comprising: contacting a mixture comprising at least one fluoroolefin and at least one RfC?CX impurity with at least one zeolite to reduce the concentration of said at least one RfC?CX impurity in said mixture;wherein:
(a) Rf is a straight-chain perfluorinated alkyl group, and X is H, F, Cl, Br or I; and
(b) said at least one zeolite is selected from the group consisting of zeolites having pore opening of at least 4 Angstroms and no more than about 5 Angstroms, zeolites having pore opening of at least about 5 Angstroms and Sanderson electronegativity of no more than about 2.6, and mixtures thereof; provided that said at least one zeolite is not zeolite 4A.
US Pat. No. 10,246,644

METHOD FOR PREPARING BIODIESEL

Tsinghua University, Bei...

1. A method for preparing biodiesel, wherein said method comprises steps of:(1) adding oil and fat, short chain alcohol, water, and liquid lipase into a single-stage or multi-stage reactor for conducting a reaction, then separating the reaction liquid into a heavy phase and a light phase; recovering and reusing the liquid lipase in the heavy phase, and using the light phase for subsequent conversion by immobilized lipase;
(2) flowing the light phase obtained in step (1) into a single-stage or multi-stage reactor containing immobilized lipase, and adding short chain alcohol for conducting a reaction; wherein an online dehydration is carried out during the whole reaction or part of the reaction.
US Pat. No. 10,246,392

OPTIMIZATION OF O-SULFONATED PHENOL PRODUCTION FOR CUMENE HYDROPEROXIDE CLEAVAGE

SABIC GLOBAL TECHNOLOGIES...

1. A method for the cleavage of a C8-12 alkylbenzene hydroperoxide into phenol and a C3-6 ketone, comprising:contacting the C8-12 alkylbenzene hydroperoxide with a catalytically sufficient amount of a sulfonated phenol under conditions effective to cleave the C8-12 alkylbenzene hydroperoxide to form the phenol, the C3-6 ketone, a C2-C6 alkylaldehyde, or a combination comprising at least one of the foregoing,
wherein the sulfonated phenol is manufactured by a method comprising
combining phenol and a sulfonating agent at a first temperature that is 1° C. to 15° C. higher than a melting temperature of the phenol, to form a reaction mixture at the first temperature,
reducing the first temperature of the reaction mixture to a second temperature that is 10 to 40° C. lower than the first temperature, and
forming the sulfonated phenol at the second temperature.
US Pat. No. 10,246,648

PROCESS FOR MANAGING SULPHUR SPECIES

CES TECHNOLOGY S.A.R.L., ...

1. A method of removing a sulphur-containing species from a sour liquid, said method comprising:(a) providing the sour liquid comprising the sulphur-containing species;
(b) introducing a halogen-based catalyst to the sour liquid, wherein the halogen-based catalyst is complexed with a second species selected from the group consisting of an ethoxylate species, a propoxylate species, and a combination thereof;
(c) introducing an oxidant to the sour liquid; and
(d) reacting the sulphur-containing species, the halogen-based catalyst and the oxidant.
US Pat. No. 10,245,625

CARBON NANOTUBE-BASED ROBUST STEAMPHOBIC SURFACES

THE UNIVERSITY OF AKRON, ...

1. A method for creating a superhydrophobic coated nanoporous assembly having steamphobic properties, the method comprising:providing a non-water soluble and heat resistant nanoporous assembly formed of discrete or continuous or both discrete and continuous structures that provide a morphology defining pores of less than 500 nm between neighboring discrete and continuous structures;
bringing gaseous plasma precursors in the presence of the nanoporous assembly and in the presence of a plasma generator;
employing the plasma generator to convert the gaseous plasma precursors to the plasma state; and
permitting the plasma precursors to deposit as a coating on the nanoporous assembly through plasma polymerization techniques the deposition thereof preserving the porous structure of the nanoporous assembly, the deposited coating exhibiting a surface energy of less than 30 dynes/cm due to the selection of plasma precursors.
US Pat. No. 10,246,393

METHOD FOR PRODUCING AROMATIC COMPOUND

TOSOH CORPORATION, Yamag...

1. A method for producing an aromatic compound represented by the following formula (3):Ar1?Ar2)n  (3)wherein Ar1, Ar2 and n are the same as defined in formulae (1) and (2),which comprises subjecting an aromatic nitro compound represented by the following formula (1):Ar1?NO2)n  (1)wherein Ar1 is an aromatic hydrocarbon group which may have a substituent or a heteroaromatic group which may have a substituent, and n is an integer of from 1 to 5;and a boronic acid compound represented by the following formula (2):Ar2—B(OR1)2  (2)wherein Ar2 is an aromatic hydrocarbon group which may have a substituent, or a heteroaromatic group which may have a substituent, R1 is each independently a hydrogen atom, a C1-4 alkyl group or a phenyl group, and the two R1 substituents may be linked to form a ring containing oxygen atoms and a boron atom;to a cross coupling reaction in the presence of a palladium or nickel compound as a transition metal catalyst.
US Pat. No. 10,246,649

PROCESS FOR REDUCING THE TOTAL ACID NUMBER IN REFINERY FEEDSTOCKS

Saudi Arabian Oil Company...

1. A process for reducing the total acid number of a refinery feedstock containing naphthenic acids, the process comprising contacting the refinery feedstock containing naphthenic acids with an effective amount of solid catalyst that has been pretreated with a caustic base for a period of time sufficient and at a temperature of at least 200 C to neutralize at least a portion of the naphthenic acids in the refinery feedstock to produce a treated product having reduced total acid number.
US Pat. No. 10,246,396

VANILLIN HAVING TETRAMER STRUCTURE

1. A vanillin having a tetramer structure, comprising a first monomer, a second monomer, a third monomer, a fourth monomer, a first intermolecular hydrogen bond between the first monomer and the fourth monomer, and a second intermolecular hydrogen bond between the second monomer and the third monomer; wherein each of the monomers is constituted by C8H8O3.
US Pat. No. 10,246,397

PROCESS FOR PRODUCTION OF KETONES FROM SECONDARY ALCOHOLS

Instituto Superior Tecnic...

1. A process for production of ketones from secondary alcohols, assisted by microwave radiation comprising the mixture of an oxidising agent with a hybrid, material dichlorohydrotris (pyrazol-1-yl) methane iron (II) covalently bound to multi-walled carbon nanotubes functionalized with superficial carboxylate groups as catalyst, at a temperature of 80° C.
US Pat. No. 10,245,887

METHODS RELATING TO POLYURETHANE FOAM-CONTAINING AND DEGRADABLE FOAM-CONTAINING TIRES, AND DEGRADABLE FOAM-CONTAINING TIRES

Bridgestrone Americas Tir...

1. A method for degrading polyurethane foam from inside of a mounted polyurethane foam-containing tire, the method comprising:a. providing a solution comprising at least one phosphorous oxoacid or an ester thereof,
b. providing a mounted tire comprising a wheel and a rubber carcass and having polyurethane foam inside the rubber carcass,
c. applying the solution to the polyurethane foam inside the rubber carcass, and
d. heating to degrade the polyurethane foam.
US Pat. No. 10,246,399

PROCESS FOR PRODUCING ACETIC ACID

DAICEL CORPORATION, Osak...

1. A process for producing acetic acid, comprising:(1) allowing methanol to carbonylation react with carbon monoxide in the presence of a catalyst system, acetic acid, methyl acetate, and water, wherein the catalyst system comprises a metal catalyst, an ionic metal iodide, and methyl iodide;
(2) separating the reaction mixture into a volatile phase and a less-volatile phase;
(3) distilling the volatile phase to form a first overhead and an acetic acid stream, wherein the first overhead is rich in at least one lower boiling component selected from the group consisting of methyl iodide and acetaldehyde, and the acetic acid stream is rich in acetic acid; and
at least one section selected from the group consisting of the following sections (4), (9), and (15):
(4) a purification section for obtaining purified acetic acid from the acetic acid stream;
(9) a separation section for separating at least acetaldehyde from the first overhead; and
(15) an off-gas treatment section for absorption-treating an off-gas from the process with an absorption solvent and forming a carbon monoxide-rich stream and an acetic acid-rich stream;
wherein a concentration of oxygen is controlled in at least one selected from the group consisting of the following (a) and (b):
(a) the concentration of oxygen in a gaseous phase of the process is controlled to less than 7% by volume,
(b) the concentration of oxygen in a liquid phase of the process is controlled to less than 7×10?5 g/g.
US Pat. No. 10,245,888

RUBBER COMPOSITION FOR TIRES AND PNEUMATIC TIRE

SUMITOMO RUBBER INDUSTRIE...

1. A pneumatic tire, comprising a tire component formed from a rubber composition for tires, the rubber composition comprising;a rubber component and
a core-shell structured particle comprising a core and a shell,whereinthe core has a melt viscosity at 38° C. of 0.1 to 3,000 Pa·s, and
the shell is formed of a polymer of at least one of a conjugated diene compound or an aromatic vinyl compound.
US Pat. No. 10,246,400

METHOD FOR THE PREPARATION OF (S)-2-ACETYLOXYPROPIONIC ACID AND DERIVATIVES THEREOF

Bracco Imaging S.P.A., M...

1. A method for preparing an (S)-2-acetyloxypropionic acid in a preparation assembly comprising a distillation section (A) and a reaction section (B), the distillation section (A) comprising a top portion and a bottom portion connected to said reaction section (B), the method comprising the steps of:a. continuously feeding an aqueous solution of a lactic acid to the top portion of the distillation section (A);
b. feeding an acetic anhydride into the reaction section (B);
c. reacting the lactic acid with the acetic anhydride in the reaction section (B), thus forming the (S)-2-acetyloxypropionic acid and an acetic acid;
d. evaporating a vapor mixture of the acetic acid and of the unreacted acetic anhydride from the reaction section (B);
e. feeding the vapor mixture of step d to the distillation section (A) for stripping water from the aqueous solution of lactic acid to form a substantially anhydrous lactic acid which counterflows through said distillation section (A) towards the reaction section (B), so that a mixture of the substantially anhydrous lactic acid and the acetic acid enters the reaction section (B) from the bottom portion of the distillation section (A);
f. recovering the (S)-2-acetyloxypropionic acid from the reaction section (B); and
g. collecting a diluted aqueous solution of the acetic acid at the top portion of the distillation section (A).
US Pat. No. 10,246,659

UNLEADED AVIATION FUEL

LANXESS Deutschland GmbH,...

1. A lead-free aviation gasoline composition having a high motor octane number and low freezing temperature, the gasoline comprising:(a) about forty-five percent (45%) to about sixty-five percent (65%) by weight of at least one unleaded gasoline base fuel having a motor octane number of between ninety-seven (97) and ninety-nine point nine (99.9);
(b) about ten percent (10%) to about thirty-five percent (35%) by weight of one or more alkylated benzenes;
(c) about six percent (6%) to about twelve percent (12%) by weight, collectively, of one or more of iso-pentane, n-butane, and iso-butane; and
(d) about four percent (4%) to about fifteen percent (15%) by weight aromatic-amines, said aromatic amines comprising N-methyl-p-toluidine in combination with at least one of N-methyl-m-toluidine and m-Toluidine, and a ratio of N-methyl-p-toluidine to the at least one of N-methyl-m-toluidine and m-Toluidine is about four to one (4:1) to twelve to one (12:1);
wherein the gasoline has a freezing point of ?58° C. or lower.
US Pat. No. 10,249,733

TRANSISTOR AND MANUFACTURING METHOD OF TRANSISTOR

FUJIFILM Corporation, To...

1. A manufacturing method of a transistor, comprising:a preparation step of preparing a laminate in which a gate electrode layer, a solid insulating layer, and a support precursor layer are laminated on a substrate in this order;
a semiconductor layer forming step of forming a semiconductor layer on an upper surface of the support precursor layer of the laminate;
an opening portion forming step of forming one or more opening portions from which the support precursor layer is exposed by removing a part of the semiconductor layer;
a protective layer forming step of forming two etching protective layers on the semiconductor layer such that the two etching protective layers are separated from each other and at least a part of the opening portion is positioned in a region between the two etching protective layers; and
a support forming step of removing a part of the support precursor layer by bringing a liquid or a gas that can etch the support precursor layer into contact with the support precursor layer through the opening portions between the two etching protective layers, thereby forming a space at a position corresponding to the region between the two etching protective layers so as to form two semiconductor layer supports that are arranged with the space interposed therebetween.
US Pat. No. 10,245,643

SINTERED BODY

Sumitomo Electric Industr...

1. A sintered body comprising a first hard particle; a second hard particle; and a binder,wherein the first hard particle is an M sialon particle having a coating layer, the M sialon particle is represented by MxSi(6?x?z)AlzOzN(8?z) (in the formula, M is a metal containing at least one selected from the group consisting of calcium, strontium, barium, scandium, yttrium, lanthanoid, manganese, iron, cobalt, nickel, copper, and group IV, group V, and group VI elements of the periodic table, and relationships of 0.01?x?2, 0.01?z?4.2, and 1.79?(6?x?z)?5.98 are satisfied), and
the second hard particle is a cubic boron nitride particle.
US Pat. No. 10,246,667

SYNERGISTIC STAIN REMOVAL THROUGH NOVEL MGDA/GLDA/STPP CHELATOR COMBINATION

Ecolab USA Inc., Saint P...

1. A concentrated detergent composition comprising:an alkali metal carbonate,
methylglycinediacetic acid,
glutamic acid N,N-diacetic acid, and
alkali meta tripolyphosphate;
wherein the total concentration of methylglycinediacetic acid, glutamic acid N,N-di acetic acid, and alkali metal tripolyphosphate is 14 to 28% by weight, and the molar ratio of glutamic acid N,N-diacetic acid to the sum of methylglycinediacetic acid and alkali metal tripolyphosphate is 0.03 to 29.
US Pat. No. 10,246,668

PROPORTIONER-READY BIOENZYMATIC CONCENTRATED CLEANING PRODUCT

Illinois Tool Works, Inc....

1. A bioenzymatic, concentrated cleaning product, comprising:15 to 55% by weight bacillus spores, capable of generating extracellular enzymes selected from the group consisting of extracellular protease enzymes, extracellular urease enzymes, extracellular amylase enzymes, extracellular lypase enzymes, extracellular cellulase enzymes, and combinations thereof;
a suspending and/ or rheology modifying agent;
an odor control agent;
sufficient pH adjuster to maintain a pH of about 5.0 to about 9.5;
and water;
wherein the 15-55% by weight bacillus spores have an average diameter of 5-50microns and remain suspended in the water under static conditions and the bioenzymatic, concentrated cleaning product is substantially free of organic solvents.
US Pat. No. 10,246,669

METHOD FOR PRODUCING HYPOALLERGENIC PEANUT PRODUCTS

Molecular Epidemiology In...

1. A method of decontaminating machinery contaminated with allergen residues, comprising: contacting machinery contaminated with seeds of legumes, peanuts or tree nuts, or unground pieces or particles thereof, having Ara h3 allergen with an aqueous solution of bromelain in an amount and for a time period sufficient to reduce or eliminate the allergenicity of the Ara h3 allergen.
US Pat. No. 10,249,486

METHOD FOR POLISHING SEMICONDUCTOR SUBSTRATE

NITTA HAAS INCORPORATED, ...

1. A method for polishing a semiconductor substrate, comprising:an intermediate polishing step if polishing in such a way that the number of surface defects having heights of less than 3 nm becomes 45% or more of the total number of the surface defects on the surface of a semiconductor substrate; and
a final polishing step of finish-polishing the semiconductor substrate after the intermediate polishing step,
wherein in the intermediate polishing step, polishing is performed by using a polishing composition comprising: hydroxyethyl cellulose, water and abrasive grains, the hydroxyethyl cellulose has a molecular weight of 500,000 or more and 1,500,000 or less, and the mass ratio of the hydroxyethyl cellulose to the abrasive grains is 0.0075 or more and 0.025 or less, and
wherein in the final polishing step, polishing is performed by using a polishing composition comprising: hydroxyethyl cellulose, water and abrasive grains, and the hydroxyethyl cellulose has a molecular weight of 300,000 or more and 1,200,000 or less, and has a different molecular weight from that of the hydroxyethyl cellulose present in the polishing composition used in the intermediate polishing step.
US Pat. No. 10,246,672

NANOLIPIDS WITH ENCAPSULATED ALCOHOL

NuVessl, Inc., Calgary (...

1. An ethanol-loaded nanolipid particle (NLP) carrier made by a process comprising the steps of:a) providing a monophasic optically clear precursor stock having phospholipids solubilized in ethanol and water;
b) diluting said precursor stock with an ethanol solvent to produce a solvent-diluted precursor stock, wherein said diluting of said precursor stock with said ethanol solvent is at a ratio ranging from about 1 part precursor stock to about 20 parts ethanol solvent (volume/volume) to a ratio ranging from about 1 part precursor stock to about 0.3 parts ethanol solvent (volume/volume), said diluting of said precursor stock resulting in one or more substantially unloaded nanolipid particle (NLP), wherein the more ethanol solvent used for said diluting of the precursor stock, the smaller the nanolipids particles will be;
c) adding an ethanol-containing substance suitable for human consumption to an aqueous solvent to produce an aqueous-ethanol monophase; and
d) combining said solvent-diluted precursor stock formed in step (b) with said aqueous-ethanol monophase from step (c), wherein said one or more substantially unloaded nanolipid particle (NLP) formed in step (b) becomes loaded with the ethanol-containing substance from step (c) as a passenger in the nanolipid particle (NLP) resulting in one or more ethanol-loaded NLP carrier sized from 20 nm to 300 nm.
US Pat. No. 10,246,673

USE OF LIGNIFIED STALKS OR OF AT LEAST ONE EXTRACT OF LIGNIFIED STALKS IN A COSMETIC COMPOSITION, A FOOD SUPPLEMENT, A NUTRITIONAL PRODUCT, A FOOD OR A BEVERAGE

1. A method for enhancing a flavor or an aroma of a beverage, comprising the steps of:lignifying stalks for 1 to 5 weeks, during which membranes of certain plant cells of the stalks are transformed, under the action of the lignin, into wood, to obtain lignified stalks; and
adding to a beverage at least one lignified stalk extract obtained from the lignified stalks in which lignified stalks are whole, in pieces, or in powder form, or a composition containing the at least one lignified stalk extract, as a flavoring agent or an aromatizing agent to enhance a flavor or an aroma of said beverage.
US Pat. No. 10,246,677

DEVICES, SYSTEMS AND METHODS FOR THE PRODUCTION OF HUMANIZED GUT COMMENSAL MICROBIOTA

1. A system for the ex vivo production of human gut microbiota, comprising:a tortuous, tubular ex vivo culture network comprising-hollow cartridges for culturing human gut microbiota, wherein the hollow cartridges are in the fluid communication and removably attached to the tortuous tubular ex vivo culture network and comprise human gut microbiota and metabolites;
a humidifying system in fluid communication with the tortuous tubular ex vivo culture network to maintain physiological humidity inside the tortuous tubular ex vivo culture network;
a temperature regulation system in contact with the tortuous tubular ex vivo culture network to regulate the temperature inside the tortuous tubular ex vivo culture network to physiological temperature; and
a hollow functional screening portal comprising extracellular matrix proteins, human cells, and metabolites generated by the microbiota in the tortuous tubular ex vivo culture network, wherein the screening portal receives oxygen and other gases for culturing the human cells from a gas system in fluid communication with the tortuous tubular ex vivo culture network, wherein the functional screening portal is separated from the microbiota column with a semi-permeable membrane; and
a tunable, gas gradient of 0.8-2.0% oxygen or 2-60 mm Hg in the tortuous tubular ex vivo culture network.
US Pat. No. 10,246,678

BIOMATRIX SCAFFOLDS

The University of North C...

1. A biomatrix scaffold produced by a method comprising:a) perfusing the biological tissue or homogenizing the biological tissue from the group consisting of liver, lung, thyroid, skin, pancreas, blood vessels, bladder, kidneys, brain, biliary tree, duodenum, abdominal aorta, iliac vein, heart, and intestines, with a first medium, wherein the osmolality of said first medium is from about 250 mOsm/kg to about 350 mOsm/kg and said first medium is serum free and at neutral pH; then
b) perfusing the biological tissue or extracting the homogenate of step (a) with a delipidating buffer comprising lipases and/or detergents in said first medium, wherein the detergents do not comprise sodium dodecyl sulfate or Triton X-100; then
c) perfusing the tissue or extracting the homogenate of step (b) with a buffer at a neutral pH and comprising a salt concentration from about 2.0 M to about 5.0 M NaCl; then
d) rinsing the tissue or homogenate of step (c) with a second medium that is at neutral pH, is serum-free and has an osomolality from about 250 mOsm/kg to about 350 mOsm/kg,
thereby producing an intact or homogenized biomatrix scaffold from the biological tissue, said biomatrix scaffold comprising at least 95% of the collagens and most collagen-associated matrix components and matrix bound growth factors, hormones and cytokines of the biological tissue.
US Pat. No. 10,246,679

METHOD FOR PRODUCING PLURIPOTENT STEM CELL HAVING IMPROVED CHIMERA FORMING ABILITY FROM PRIMED PLURIPOTENT STEM CELL, AND COMPOSITION AND COMBINATION THEREFOR

THE UNIVERSITY OF TOKYO, ...

1. A method of increasing chimera forming ability of a primed pluripotent stem cell, comprising treating a primed pluripotent stem cell with a Wnt/?-catenin signal transduction selective inhibitor and a signal transducer and activator of transcription 3 (STAT3) activator to place the primed pluripotent stem cell in a state where a Wnt/?-catenin signal is selectively inhibited, among Wnt signaling pathways, and a STAT3 signal is activated, wherein following the treatment the primed pluripotent stem cell has increased chimera forming ability compared to an untreated control primed pluripotent stem cell.
US Pat. No. 10,246,680

METHODS AND COMPOSITIONS FOR FEEDER-FREE PLURIPOTENT STEM CELL MEDIA CONTAINING HUMAN SERUM

VIACYTE, INC., San Diego...

1. A composition comprising human pluripotent stem cells and a medium comprising an effective amount of a soluble human serum attachment component, wherein the human pluripotent stem cells are in contact with the medium in a culture vessel that is not pre-coated with an extracellular matrix and wherein the effective amount of the soluble human serum attachment component promotes growth of the human pluripotent stem cells.
US Pat. No. 10,246,681

REPROGRAMMING OF HUMAN WHARTON'S JELLY CELLS TO PRODUCE HAIR CELLS

The University of Kansas,...

1. A cell culture system comprising:a decellularized cochlea; and
mechanosensory hair cells (MHCs) growing on and/or inside the decellularized cochlea, wherein the MHCs have an exogenous nucleic acid that encodes HATH1 and a promoter operably linked with the encoded HATH1.
US Pat. No. 10,246,682

METHODS OF CULTURING RETINAL PIGMENTED EPITHELIUM CELLS, INCLUDING XENO-FREE PRODUCTION, RPE ENRICHMENT, AND CRYOPRESERVATION

The Regents of the Univer...

1. A method of producing RPE cells from pluripotent cells under xeno-free culture conditions, comprising(a) culturing pluripotent cells on a first xeno-free substrate in a xeno-free growth medium supplemented with one or more compositions which substantially maintains pluripotent cells in a pluripotent state, wherein the pluripotent cells are embryonic stem cells or induced pluripotent stem cells;
(b) replacing the xeno-free growth medium with a xeno-free growth medium lacking any composition which maintains cells in a pluripotent state, wherein the cultured cells have not reached confluence at the time of such replacement of growth medium;
(c) allowing the cultured cells on the first xeno-free substrate to undergo spontaneous differentiation, which results in some of the pluripotent cells differentiating into RPE cells;
(d) treating the cultured cells on the first xeno-free substrate with a solution comprising a dissociation agent for a first interval of time, removing the solution comprising the dissociation agent, and immediately thereafter washing the first xeno-free substrate with buffer or medium;
(e) physically separating cells other than mature RPE cells from the first xeno-free substrate;
(f) treating the cultured cells remaining on the first xeno-free substrate with a solution comprising a dissociation agent for a second interval of time;
(g) physically separating the mature RPE cells from the first xeno-free substrate to yield isolated RPE cells; and
(h) culturing the isolated RPE cells on a second xeno-free substrate in xeno-free growth medium.
US Pat. No. 10,246,683

METHOD AND ASSEMBLY FOR EXTRACTION OF REGENERATIVE CELLULAR COMPONENTS FROM ADIPOSE TISSUE

MyStem Limited, Nicosia ...

1. A method for extracting regenerative cellular components from adipose tissue comprising the steps of:a) filtering a harvested adipose tissue for recovering its liquid fraction by means of a filtering element having a first cut-off value between 40 microns and 70 microns;
b) separating regenerative cellular components present in the liquid fraction by means of cell size segregation, which blocks cells bigger than a second cut-off value ranging from 8 to 20 microns; and
c) recovering the liquid regenerative cells-rich fraction comprising the regenerative cellular components not having being blocked during the separating step b);wherein steps a)-c) are carried out in a time ranging from 1 to 5 minutes.
US Pat. No. 10,246,428

INSENSITIVE PLASTICIZER AND MELT-CASTABLE ENERGETIC MATERIAL

The United States of Amer...

1. A method comprising:mixing dichloroglyoxime with an alcohol containing an alkyne functional group in methanol to create a mixture;
adding a salt compound and water to said mixture to create bis-isoxazole diol; and
nitrating said bis-isoxazole diol to create 3,3?-bis-isoxazole-5,5?-bis-methylene dinitrate.
US Pat. No. 10,246,685

RECOMBINANT MDV1 AND THE USES THEREOF

CEVA SANTE ANIMALE, Libo...

1. A recombinant Marek's Disease Virus serotype 1 (rMDV1) comprising a foreign gene in its genome, wherein said foreign gene is located in an untranslated genetic region of the genome, and wherein said untranslated genetic region is located between MDV010 and MDV011, between MDV015.5 and MDV016, between MDV033 and MDV034, between MDV071 and MDV072, or between MDV096 and MDV097.6 of the genome.
US Pat. No. 10,246,686

INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT

Wisconsin Alumni Research...

1. An isolated recombinant, reassortant influenza virus having PA, PB1, PB2, NP, NS, and M viral segments from a first influenza vaccine virus isolate, a heterologous, recombinant or chimeric influenza virus NA viral segment, and a heterologous, recombinant or chimeric HA viral segment, wherein the PB1 viral segment encodes a polypeptide having an alanine at residue 62, a glycine at residue 261, an arginine at residue 361, an arginine at residue 621, a serine at residue 654 or a glycine at residue 81 in F2, or a combination thereof, which PB1 viral segment encodes a PB1 having at least 85% amino acid sequence identity to a polypeptide encoded by SEQ ID NO:2; or wherein the PB2 viral segment encodes a polypeptide having a lysine at residue 391 and having at least 85% amino acid sequence identity to a polypeptide encoded by SEQ ID NO:3; or wherein the HA viral segment encodes a HA having an aspartic acid at position 136, a glutamic acid at position 162 or position 449, a leucine at position 179, a valine at position 182, an isoleucine at any of positions 184, 252 or 476, or any combination thereof; or wherein the NA viral segment encodes a NA having a serine at position 55 or a valine at position 265, or a combination thereof; and/or wherein the NS viral segment encodes a NS1 polypeptide having a lysine at position 118, and having at least 85% amino acid sequence identity to a NS1 polypeptide encoded by SEQ ID NO:6.
US Pat. No. 10,246,431

PROCESS TO EXTRACT AND PURIFY ?9-TETRAHYDROCANNABINOL

Axim Biotechnologies, Inc...

1. A method of producing delta9-THC consisting essentially of:extracting delta9-THC carboxylic acid from cannabis flowers using heptane to obtain a heptane extract;
filtering the heptane extract to remove solid plant matter;
separating the delta9-THC carboxylic acid from the heptane extract by contacting the heptane extract with sodium chloride water adjusted to a pH range of 13.2 to 13.4 using an inorganic base to form a liquid mixture; stirring the liquid mixture; and leaving the liquid mixture to settle, wherein the liquid mixture forms three layers consisting of a first organic layer, a second oily layer, and third aqueous layer; and
separating out the oily layer from the other two layers to yield the delta9-THC.
US Pat. No. 10,246,687

KETOREDUCTASE POLYPEPTIDES

Codexis, Inc., Redwood C...

1. An engineered polypeptide having ketoreductase activity, wherein said engineered polypeptide comprises a region with an amino acid sequence having at least 90% sequence identity to residues 90 to 211 of SEQ ID NO: 130, comprising a substitution at position X190, and further comprising one or more of the following features selected from:residue corresponding to X94 is asparagine, glycine, serine, or a polar residue;
residue corresponding to X95 is an aliphatic residue;
residue corresponding to X96 is glutamine, asparagine, or threonine;
residue corresponding to X101 is an acidic, non-polar, or a polar residue;
residue corresponding to X105 is an acidic or non-polar residue;
residue corresponding to X108 is a hydrophilic, polar or constrained residue;
residue corresponding to X111 is a non-polar or aliphatic residue;
residue corresponding to X112 is an acidic or polar residue;
residue corresponding to X113 is a non-polar or aliphatic residue;
residue corresponding to X117 is a non-polar or a polar residue;
residue corresponding to X127 is a basic residue;
residue corresponding to X147 is a non-polar, aliphatic, aromatic, or hydrophobic residue;
residue corresponding to X152 is a non-polar, basic, or hydrophilic residue;
residue corresponding to X157 is a polar residue;
residue corresponding to X163 is a non-polar or aliphatic residue;
residue corresponding to X176 is a non-polar or aliphatic residue;
residue corresponding to X194 is a constrained, basic, or polar residue;
residue corresponding to X197 is a hydrophilic, acidic, basic, aliphatic or a non-polar residue;
residue corresponding to X198 is an acidic, basic, hydrophilic, or non-polar residue;
residue corresponding to X199 is an acidic, aliphatic, or non-polar residue;
residue corresponding to X200 is an acidic or constrained residue;
residue corresponding to X202 is a non-polar residue;
residue corresponding to X206 is a non-polar, aromatic, or hydrophobic residue;
residue corresponding to X211 is a basic residue, and
wherein the amino acid sequence can optionally have one or more differences at other amino acid residues in the domain as compared to the reference sequence.
US Pat. No. 10,247,711

QUALITY CONTROL REAGENTS AND METHODS

Promega Corporation, Mad...

1. A peptide mixture comprising three or more distinct-mass versions of each of two or more distinct-sequence peptides, wherein two or more of the distinct-sequence peptides are selected from SEQ ID NOS: 1-6, and wherein two or more of the distinct-mass versions of each distinct-sequence peptide comprises one or more amino acids with above natural-abundance levels of one or more heavy isotopes.
US Pat. No. 10,246,688

DITERPENOID SYNTHESIS

The University of York, ...

1. A transgenic fungal cell comprising an expression vector adapted to express a nucleic acid molecule, wherein the nucleic acid molecule comprises:i) the nucleotide sequence of SEQ ID NO: 6;
ii) a nucleotide sequence comprising at least 90% identity to SEQ ID NO: 6 and that encodes a polypeptide having cytochrome P450 activity; or
iii) a nucleotide sequence degenerate as a result of the genetic code to the nucleotide sequence of SEQ ID NO: 6 and encodes a polypeptide comprising SEQ ID NO: 32 and that has cytochrome P450 activity;or wherein the nucleic acid molecule comprises:iv) the nucleotide sequence of SEQ ID NO: 18;
v) a nucleotide sequence comprising at least 90% identity to SEQ ID NO: 18 and that encodes a polypeptide having cytochrome P450 activity; or
vi) a nucleotide sequence degenerate as a result of the genetic code to the nucleotide sequence of SEQ ID NO: 18 and encodes the polypeptide of SEQ ID NO: 44 and that has cytochrome P450 activity.
US Pat. No. 10,246,689

VARIANT LOVD POLYPEPTIDE

THE REGENTS OF THE UNIVER...

1. A variant of a LovD polypeptide, wherein:the variant LovD polypeptide comprises a functional LovD acyltransferase with an amino acid sequence having at least 90% identity to SEQ ID NO:1; and
the variant LovD polypeptide comprises an amino acid substitution at amino acid residue position D12 and at least one further amino acid substitution selected from the group consisting of K26E, G275S, and L361M.
US Pat. No. 10,246,690

MUTANT HYDROLASE PROTEINS WITH ENHANCED KINETICS AND FUNCTIONAL EXPRESSION

Promega Corporation, Mad...

1. A polypeptide comprising a mutant dehalogenase that is capable of catalyzing hydrolytic dehalogenation of an alkylhalide substrate and forming a covalent ester intermediate with the substrate, said mutant dehalogenase having at least 85% sequence identity with the polypeptide of SEQ ID NO: 1; wherein said mutant dehalogenase comprises substitutions at:(a) one or more positions corresponding to positions in SEQ ID NO: 1 selected from the group consisting of positions 106 and 272; and
(b) positions corresponding to positions 58, 78, 155, 167, 172, 224, and 291 of SEQ ID NO: 1.
US Pat. No. 10,246,691

VARIANTS OF POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME

Novozymes, Inc., Davis, ...

1. A variant of a parent GH61 polypeptide having cellulolytic enhancing activity, comprising a substitution at one or more positions corresponding to positions 90, 131, 134, and 141 of the full-length polypeptide of SEQ ID NO: 2, wherein the substitution at a position corresponding to position 90 is with Val, the substitution at a position corresponding to position 131 is with Ser, the substitution at a position corresponding to position 134 is with Leu, and the substitution at a position corresponding to position 141 is with Trp, wherein the variant has cellulolytic enhancing activity and increased thermal activity and/or increased thermostability, and wherein the variant hasat least 95% sequence identity to the mature polypeptide of SEQ ID NO: 2.
US Pat. No. 10,246,692

POLYPEPTIDES HAVING LIPASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME

1. A composition comprising an isolated polypeptide having lipase activity and having at least 94% sequence identity to the sequence of amino acids 1 to 292 of SEQ ID NO: 2, and one or more anionic surfactants,wherein the anionic surfactants are present at a level of from 0.1 to 60 wt %,
wherein the composition is formulated at a pH from 8.0 to 11, and
wherein the composition is more effective in removing lipid stains present at a surface in comparison with an equivalent composition lacking the lipase.
US Pat. No. 10,247,716

ANTIBODY AND RECOMBINANT DERIVATIVE FOR THE DETECTION OF TRINITROTOLUENE

The United States of Amer...

1. An isolated and purified antibody or functional fragment thereof that binds to trinitrotoluene, comprising:a heavy chain having the sequence of SEQ ID No: 1 but with one or more mutations selected from the group consisting of: N35S, Q39K, L45S, and W47Y and a light chain having the sequence of SEQ ID No: 2.
US Pat. No. 10,246,693

POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME

Novozymes, Inc., Davis, ...

1. A DNA construct or recombinant expression vector comprising an isolated polynucleotide comprising a nucleotide sequence that encodes a GH61 polypeptide having cellulolytic enhancing activity, wherein the isolated polynucleotide is operably linked to one or more heterologous control sequences that direct the production of the polypeptide in an expression host, and wherein the GH61 polypeptide having cellulolytic enhancing activity is selected from:(a) a GH61 polypeptide having at least 95% sequence identity to amino acids 20 to 223 of SEQ ID NO: 8; and
(b) a GH61 polypeptide encoded by a polynucleotide having at least 99% sequence identity to nucleotides 58 to 974 of SEQ ID NO: 7, or a GH61 polypeptide encoded by the cDNA of nucleotides 58 to 974 of SEQ ID NO: 7.
US Pat. No. 10,246,694

PHOSPHOKETOLASES FOR IMPROVED PRODUCTION OF ACETYL COENZYME A-DERIVED METABOLITES, ISOPRENE, ISOPRENOID PRECURSORS, AND ISOPRENOIDS

DANISCO US INC., Palo Al...

1. A recombinant cell capable of increased carbon flux through the phosphoketolase pathway, wherein the recombinant cell comprises: (i) a heterologous nucleic acid sequence encoding a polypeptide having phosphoketolase activity, wherein the polypeptide comprises at least 65% sequence identity to SEQ ID NO:8 or SEQ ID NO:11 and (ii) one or more nucleic acids encoding one or more polypeptides of the complete mevalonate (MVA) pathway, wherein the recombinant cell is a recombinant Escherichia coli cell, and wherein(1) said recombinant cell comprising said polypeptide having phosphoketolase activity of (i) has a Performance Index value of greater than 1.0 in one or more of the following parameters: (a) cell growth on glucose, (b) cell growth on xylose, (c) production of intracellular acetyl-phosphate or (d) cell growth on glucose-6-phosphate, wherein the Performance Index value is calculated as activity per unit relative to a corresponding cell expressing a phosphoketolase from E. gallinarum or
(2) said polypeptide having phosphoketolase activity of (i) has a Performance Index value of greater than 1.0 in one or more of the following parameters: (e) protein solubility, (f) protein expression, or (g) fructose-6-phosphate (F6P) Specific Activity, wherein the Performance Index value is calculated as activity per unit relative to a phosphoketolase from E. gallinarum.
US Pat. No. 10,248,230

WINDOW PANEL AND WINDOW PANEL INTEGRATED TYPE TOUCH SCREEN PANEL

LG Display Co., Ltd., Se...

1. A window panel for a display apparatus, comprising a window area and a peripheral area surrounding the window area and integral with the window area,wherein the window panel includes:
a top surface including an upper reinforced layer;
a bottom surface including a lower reinforced layer; and
a side surface including a first portion composed of a side reinforced layer and a second portion composed of a non-reinforced portion,
wherein the first portion and the second portion of the side surface each connect an edge of the top surface of the window panel to an edge of the bottom surface of the window panel, and
wherein the upper reinforced layer, the lower reinforced layer, and the side reinforced layer each have a higher surface density than the non-reinforced portion.
US Pat. No. 10,246,695

METHYL BUTENOL SYNTHASE

Board of Trustees of Mich...

1. An isolated and purified methyl butenol (MBO) synthase cDNA molecule, wherein the MBO synthase cDNA molecule comprising any one of SEQ ID NOs: 12-17 or at least 95% identity thereto, or a cDNA molecule encoding MBO synthase polypeptide comprising any one of SEQ ID NOs: 29-34.